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Abstract  
Speech intelligibility of 10 individuals with OMD was measured before and after receiving 
BoNT-A injections. Intelligibility was assessed using the PIT (single-word intelligibility), SIT 
(sentence intelligibility), and a conversational speech task. Five listeners rated the speech 
intelligibility of these three intelligibility tasks via orthographic transcription and visual analogue 
scaling (VAS) techniques. BoNT-A was not associated with significant differences in speech 
intelligibility. Further analysis revealed a significant difference on the PIT VAS intelligibility 
ratings based on order of presentation, suggesting that listeners rated the first half of words on 
the PIT (words 1-29)  as more intelligible than the second half of words (words 30-57). There 
was also a significant difference in SIT transcription intelligibility scores based on sentence 
length, suggesting that listeners rated shorter sentences with higher intelligibility than longer 
sentences. This research will contribute to a small body of literature on speech intelligibility in 
OMD.  
 
Keywords: speech intelligibility, oromandibular dystonia, botulinum toxin A, motor speech 
disorders, dysarthria, hyperkinetic dysarthria, speech production measurement, speech perception 
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Chapter 1 
1 Introduction 
1.1 Dystonia 
 Dystonia is defined as a neuromuscular disorder characterized by prolonged 
muscle contractions, causing repetitive movements and abnormal posturing (Brin & Comella, 
2004; Jankovic, 2005; Shanker & Bressman, 2012). Dystonic contractions have been observed to 
be slower than those of tic disorders (Comella, 2005). There are currently no definitive tests or 
imaging techniques used to diagnose dystonia (Comella, 2005).  
Dystonia can be classified in three different ways: distribution, age of onset, and etiology 
(Brin & Comella, 2004). It may be classified based on the distribution of body areas affected. 
There are five main categories, namely, focal, segmental, hemidystonia, multi-focal, or 
generalized. Focal dystonia is the most common category and is characterized by contractions of 
a single body region (Shanker & Bressman, 2012). Segmental dystonia results when more than 
one adjacent body regions are affected. Multi-focal dystonia occurs in non-adjacent distribution 
of affected regions. Hemidystonia is a subcategory of multi-focal dystonia which affects the arm 
and leg of the same side of the body. Lastly, generalized dystonia refers to the involvement of 
one two or more segments of the entire body, typically either the other leg or the trunk (Shanker 
& Bressman, 2012; Thyagarajan, 1999).  
Dystonia can develop at any stage of the lifespan, from childhood to adulthood. Early 
onset primary dystonia, which occurs before the age of 20, has a mode of 9 years old, while late 
onset primary dystonia, which occurs after the age of 20, has a mode of 45 years old (Defazio, 
Abbruzzese, Livrea, & Berardelli, 2004; Shanker & Bressman, 2012). Age of onset is related to 
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disease spread making age of symptom onset an important determiner of prognosis. Typically, 
the earlier the age of onset, the higher the probability that dystonic symptoms will spread 
towards other regions of the body (Albanese et al., 2006).  
When classifying based on etiology, dystonia can be either primary or secondary. If the 
condition is characterized by the absence of other clinical symptoms other than the dystonia itself 
and no identifiable cause has been found, it is known is primary or idiopathic dystonia (Brin & 
Comella, 2004). This means that the patient must not have any history of neurological 
abnormalities or genetic history that could lead to dystonia. In contrast, if the condition is 
symptomatic of drug use or disease, it is classified as secondary dystonia (Kaji, 2003; 
Thyagarajan, 1999). Drug-induced dystonia can be classified as either acute or tardive. Acute 
drug-induced dystonia occurs within a few days of antipsychotic treatment and can be treated 
with anticholinergic or antihistaminic drugs (Raja, 1998; van Harten, Hoek, & Kahn, 1999). 
Tardive drug-induced dystonia is associated with long-term use of antidopaminergics and is 
potentially irreversible (Raja, 1998; Tan & Jankovic, 2000; van Harten, Hoek, & Kahn, 1999). 
Examples of drugs associated with tardive dystonia are antiemetics such as droperidol, 
metoclopramide, prochlorperazine, and promethazine, psychotropics such as amoxapine, and 
neuroleptics, such as haloperidol and phenothiazines (Claxton, Chen, & Swope, 2007).  
Hemidystonia is usually secondary (Thyagarajan, 1999). Diseases that can result in secondary 
dystonia are Parkinson’s disease, multiple sclerosis, encephalitis, Huntington’s disease, and 
stroke (Shanker & Bressman, 2012). Spinocerebellar ataxia type 8 (SCA8) has also been 
associated with oromandibular and lingual dystonia (Ushe & Perlmutter, 2012).  
Although the exact cause of dystonia is unknown, it has been recognized as a disease 
involving basal ganglia (Kaji, 2003; Tsui, 2005; Shanker & Bressman, 2012).  Additionally, the 
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DYT1, genes have been noted to play a role in the onset of dystonia (Tsui, 2005, Tagliati, 
Pourfar, & Bressman, 2005).  
The basal ganglia refer to a group of nuclei in the central nervous system that plan and 
execute motor movements (Mink, 2003). Lesions isolated to the putamen and globus pallidus of 
the basal ganglia are the most frequently associated with dystonia (Bhatia & Marsden, 1994). 
The extent of basal ganglia involvement in dystonia remains poorly understood; however, it has 
been hypothesized that dystonia results from reduced firing of neurons within the globus pallidus 
interna (GPi) . This decreased activity of GPi neurons leads to incomplete inhibition of 
competing motor movement patterns. Reduced inhibition of these surrounding motor patterns 
can lead to the involuntary contraction of neighbouring muscles (Mink, 2003).  
The DYT1 gene has been implicated in causing the greatest number of primary dystonias 
that have been genetically researched (Tagliati et al., 2005). A deletion of a GAG sequence in 
DYT1 leads to dystonia (Tagliati et al., 2005). The DYT1 gene encodes torsinA, a protein that is 
involved in vesicle fusion and cytoskeletal dynamics (Tagliati et al., 2005).  
1.2 Oromandibular Dystonia and Hyperkinetic Dysarthria  
Oromandibular dystonia (OMD) is a focal dystonia affecting the mouth and face regions 
(Tan, 2004). It consists primarily of forceful involuntary muscular contractions of the face and 
tongue. These contractions may either be sustained or repetitive. Other terms for OMD are 
orofacial-buccal dystonia, jaw dystonia, lingual dystonia, cranial dystonia, and adult-onset facial 
dystonia (Schneider & Hoffman, 2011). In some cases, OMD occurs with blepharospasm, or 
involuntary contractions of the eyelids. This condition is called Meige’s syndrome.  
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Because OMD involves contraction of the facial muscles, it may produce difficulty in 
mastication and swallowing (Bhidayasiri, Cardoso, & Truong, 2006; Lee, 2007). It may also lead 
to difficulties in opening and closing the mandible, and controlling the tongue and lips. These 
difficulties may lead to dysarthria, a cluster of speech disorders caused by neurological damage 
(Tan, 2004). Dysarthria is a disruption in speech movements, involving disturbances to muscle 
tone, reflexes, rate of speech, and accuracy (Freed, 2000). Dysarthria may or may not occur with 
other language disturbances.  
There are several different types of dysarthria; however, the kind most associated with 
oromandibular dystonia is hyperkinetic dysarthria. Hyperkinetic dysarthrias refer to a 
heterogeneous group of motor speech disorders that are characterized by involuntary muscle 
movements (Duffy, 2013). Hyperkinetic dysarthrias may affect the respiratory, phonatory, 
resonatory, and articulatory aspects of speech, and may also affect prosody (Duffy, 2013).  
Hyperkinetic dysarthria, as a singular term, however, identifies a specific type of involuntary 
muscle movement that affects speech production (Duffy, 2013). The speech of patients with 
hyperkinetic dysarthria typically contains irregular breathing patterns, imprecise articulation, and 
abrupt changes in pitch, rate, and loudness (Darley, Aronson, & Brown, 1969b). These speech 
characteristics may contribute to a reduction in speech intelligibility, but do not all necessarily 
occur together in every type of hyperkinetic dysarthria. In other words, hyperkinetic dysarthria 
may be associated with different dysarthric profiles depending on the associated movement 
disorder. For example, in addition to OMD, hyperkinetic dysarthria is associated with 
Huntington’s chorea, spasmodic dysphonia, and voice tremor, all of which present with unique 
and distinctive speech characteristics. Chorea involves motor unsteadiness and quick, 
unpredictable muscle movements (Duffy, 2013). The distinctive speech features encountered in 
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hyperkinetic dysarthria of chorea are articulatory, prosodic, and phonatory in nature and include 
imprecise consonants, prolonged intervals, variable rate, and inappropriate silences (Darley et al. 
1969a). In hyperkinetic dysarthria associated with dystonia, the most affected aspects of speech 
are primarily articulatory in nature, and include imprecise consonants, distorted vowels, and 
irregular articulatory breakdowns (Duffy, 2013).  The muscle movements of OMD are distinct 
from those of chorea. Dystonic muscle movements are slower than in chorea, and have been 
characterized as following a waxing and waning pattern (Duffy, 2013). Dystonia and chorea 
differ in the rhythm, range, and force of their muscular movements (Darley et al. 1969b). 
Specifically, the rhythm of individual muscle movements in dystonia involves slow involuntary 
movements, while those of chorea involve both quick and slow movements. Additionally, the 
muscle movements in dystonia can be characterized as having a reduced to normal range, while 
those in chorea present with reduced to excessive movements. Lastly, the force of muscle 
movements in dystonia is considered normal, while that of chorea is considered reduced to 
excessive (Darley et al., 1969b).  Spasmodic dysphonia is also associated with hyperkinetic 
dysarthria. Spasmodic dysphonia refers to a group of voice disorders resulting from dystonic 
movements of laryngeal muscles (Duffy, 2013). Unlike chorea and OMD which primarily 
involve articulatory difficulties, spasmodic dysphonia refers to a group of voice disorders 
involving strained, jerky, and breathy voice qualities and (Duffy, 2013). The perceptual aspects 
of speech that are most affected by hyperkinetic dysarthria of spasmodic dysphonia are primarily 
phonatory, respiratory, and resonant in nature and involve strained, squeezed, and effortful voice 
quality, breathy or aphonic segments, and inappropriate silences (Duffy, 2013).  These qualities 
differ from the characteristics of voice tremor, which is another example of a voice disorder 
associated with hyperkinetic dysarthria. It is distinct from, but sometimes associated with, 
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movement disorders such as dystonia (Duffy, 2013). Hyperkinetic dysarthria of voice tremor is 
characterized by pitch and loudness variability and shaky or jerky voice quality (Duffy, 2013). 
Additionally, tremor of neighbouring muscles, such as the jaw, lips, and tongue may be present 
during phonation (Duffy, 2013).  
1.3 Subtypes of OMD and Muscle Involvement 
OMD can occur with various severities and clinical presentations.  It is characterized 
according to the affected muscles and its physical manifestation in a patient. OMD is most 
commonly categorized as jaw-closing, jaw-opening, jaw-deviation, tongue protrusion, tongue 
elevation, lip protrusion, and lip retraction (Bakke, Larsen, Dalager, & Møller, 2013, Kleopa & 
Kyriakides, 2003; Muller et al., 2002). One type of OMD can be secondary to another type of 
OMD. The affected muscles will likely determine the type of OMD a patient will have. 
Observations of patients’ abnormal muscle posturing can inform clinicians in identifying the 
subtype of OMD (Cultrara, Chitkara, & Blitzer, 2004).  
Jaw-opening dystonia primarily involves abnormal activity of the anterior digastric and 
external pterygoids, while the genioglossus, and geniohyoid muscles play a secondary role in 
jaw-opening activity (Cultrara et al., 2004). Involvement of the platysma has also been reported 
to be associated with jaw-opening OMD (Bhidayasiri, Cardoso, & Truong, 2006). Therefore, if 
these muscles present with dystonic symptoms, the patient will likely present with jaw-opening 
OMD. Alternatively, jaw-closing OMD involves the masseter, temporalis, and internal pterygoid 
muscles, and can lead to jaw-clenching and grinding of teeth (Bhidayasiri et al., 2006; Cultrara et 
al., 2004). The involvement of the external pterygoid muscles has been associated with jaw-
deviation and jaw-protrusion OMD (Bhidayasiri et al., 2006; Cultrara et al., 2004). Lingual 
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dystonia, specifically tongue protrusion, commonly involves the hyperactivity of the extrinsic 
tongue muscles, specifically the  genioglossus, hypoglossus, chondroglossus, styloglossus, and 
palataglossus (Bhidayasiri et al., 2006; Esper, Freeman, & Factor, 2010). The hyoglossus has 
been implicated in depression of the tongue (Bhidayasiri et al., 2006). Lip protrusion dystonia 
involves the depressor anguli oris and depressor labii inferioris muscles (Kleopa & Kyriakides, 
2003). The orbicularis oris pars labialis muscle is involved in lip retraction dystonia (Muller et 
al., 2002).  
1.4 Treatment of OMD 
OMD is among the most challenging types of dystonia to treat (Jankovic, 2004). Because 
of the various clinical presentations and severities of OMD, it has become a challenge among 
clinicians to properly diagnose this condition (Balasubramaniam, Rasmussen, Carlson, Van 
Sickels, & Okeson, 2008). Currently, there is no gold standard for diagnosing OMD, but it has 
been reported that early detection and a thorough understanding of the anatomy and physiology 
of the face and mouth area is crucial in proper diagnosis (Balasubramaniam et al., 2008). Use of 
psychological evaluations have also been suggested to identify potential psychogenic causes 
(Balasubramaniam et al., 2008). 
The use of sensory tricks, or gestes antagonistes, is not considered a long-term treatment 
for OMD but nonetheless has been reported to provide temporary relief of dystonic symptoms 
and postures (Baik, Park, & Kim, 2004; Bakke et al., 2013; Esper et al., 2010; Felicio et al., 
2010). The tactile stimulation that comes from sensory tricks modifies the hyperactive muscle 
activity and reduces dystonic postures (Bakke et al., 2013). It has been suggested that the relief 
of dystonic symptoms occurs through the activation of different sensory pathways (Giladi, 1997). 
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Examples of commonly employed sensory tricks for OMD include chewing gum, touching the 
lips or chin, biting a toothpick or straw, and humming.  
There are many available clinical treatments for OMD. These include pharmacological 
treatments, dental appliances, and chemodenervation using botulinum toxin type A. In rare cases, 
surgical intervention is also possible. The most common oral medications for OMD are 
anticholinergic drugs such as trihexylphenidyl, dopaminergics, dopamine receptor blockers, 
carbamezapines, and baclofen (Tsui, 2005). Oral baclofen has been shown to be commonly used 
in OMD (Tan, 2004; Tsui, 2005; Jankovic, 2005), and has been reported to be effective in 20% 
of patients with OMD (Tsui, 2005). In general, treatment of OMD using pharmaceuticals has 
been reported to be unremarkable and reports of side effects have been high (Cultrara, et al., 
2004, Jankovic, 2004; Tsui, 2005).  
A bite-block is an example of a dental appliance that can be used for the treatment for 
OMD. Bite-block therapy was used by Dworkin (1996) with the goal of controlling orofacial 
hyperkinetic muscle activity in two individuals with Meige’s syndrome. A bite-block is a small 
piece of dental compound that has been molded to fit the patient’s dental anatomy. Use of the 
bite-block was found to have successfully improved dystonic symptoms in patients and improved 
speech intelligibility. Specifically, patients reported the use of the bite-block helped stabilize 
jaw-clenching and twisting movements. Unfortunately, this form of treatment has no carry-over 
effects because baseline symptoms immediately returned after removal of the bite-block 
(Dworkin, 1996). 
A recent study by Schneider & Hoffman (2011) investigated the use of a dental appliance 
in a 60 year old female patient with OMD. This patient presented with hyperkinetic dysarthria 
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associated with oromandibular and lingual dystonia. Additionally, this patient also presented 
with difficulty articulating sounds involving mandibular opening and back-of-tongue elevation. 
The patient was found to be unresponsive to pharmacological treatments. It was found that the 
use of a maxillary acrylic resin appliance improved the patient’s symptoms of dystonia, however, 
this improvement was not found to be permanent. Symptoms were found to have returned within 
three months of use. Despite the current lack of literature explaining this finding, it was 
hypothesized by the investigators that the change in relative position of the articulators may have 
caused the decline in OMD symptoms, which later recurred once the nervous system has become 
accustomed to the positioning (Scheider & Hoffman, 2011).  
It was the introduction of botulinum toxin in the 1980s that revolutionized the treatment 
of OMD. Botulinum toxin has been a potent tool in the treatment of disorders involving 
uncontrollable muscle contractions. It is delivered to affected muscles via subcutaneous 
intramuscular injection to block neurotransmitter release (Fishman, 2005). Botulinum toxin A 
(BoNT-A), known commercially as Botox ® (Allergan, Inc. Irvine, CA, USA), has been used in 
the treatment of blepharospasm, involuntary jaw opening, and OMD (Batla, Stamelou, & Bhatia, 
2012; Bhattacharyya & Tarsy, 2001; Cultrara et al., 2004). Improvement of symptoms due to 
BoNT-A therapy has been known to last about 8 – 16 weeks (Clark, 2003). Not only is 
botulinum toxin effective in alleviating symptoms of dystonia, but research has also shown that 
use of botulinum toxin is effective in improving the quality of life with patients with OMD, 
including the subdomains of social support and physical health (Bhattacharyya & Tarsy, 2001). 
Similarly, it has also been found that BoNT-A injections are effective at improving domains of 
activity and participation, as well as improving social, emotional, and vocational aspects of 
general well-being (Dykstra, Adams, & Jog, 2007). Investigating consequences on the subjective 
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well-being in individuals with dysarthria is important because it has been suggested that even 
mild-moderate cases of dysarthria can have significant negative effects on an individuals’ self-
esteem and self-image (Dykstra et al., 2007). Measuring patients’ perception of their disability in 
combination with objective assessments may contribute to developing a holistic measure of their 
condition (Dykstra et al., 2007).  
There are several commercially available preparations of BoNT-A. Some commonly used 
preparations include Botox® (Allergan, Inc. Irvine, CA, USA), Dysport® (Ispen Ltd., Slough, 
Berkshire, UK), and Xeomin® (Merz Pharmaceuticals, Frankfurt, Germany). Xeomin® differs 
from Botox® and Dysport® in that it is the first BoNT-A preparation lacking in complexing 
proteins that do not have therapeutic purposes (Frevert, 2009). Differences in potency and 
dosage of commercially available types of BoNT-A have been compared by Bhidayasiri et al. 
(2006). Botox® and Xeomin® appear to have equal potency and efficacy (Frevert, 2009) and it 
has been suggested that Botox® and Xeomin® are exchangeable following a 1:1 conversion 
ratio (Dressler, 2009). The recommended starting dose for Botox® is smaller than that of 
Dysport® as a single unit of Botox® is reported to be three to five times as potent as a single 
unit of Dysport® (Huang, Foster, & Rogachefsky, 2000). For jaw-closing OMD, a dosage of 
about 50 units of Botox or 100 units of Dysport® has been recommended for the masseter and 
temporalis (Bhidayasiri et al., 2006). In cases of jaw-opening OMD, a recommended starting 
dose to the muscles of the submental complex is 20 units of Botox® or 90 units of Dysport® 
(Bhidayasiri et al., 2006). Subsequent dosages are adjusted according to the patient’s response.  
Currently, there is no clinical standardization on the use of BoNT-A (Huang, Foster, & 
Rogachefsky, 2000).  It is recommended that treatment be specific to the needs and symptoms of 
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each individual patient. The effects of BoNT-A is dependent on the location of injection, 
concentration, and volume of solution used (Huang, Foster, & Rogachefsky, 2000).  
In rare cases where patients are found to be nonresponsive to pharmacological treatments 
or botulinum toxin and are experiencing significant functional disability, surgical treatments are 
available (Balasubramaniam et al., 2008; Tsui, 2005). In a recent study by Balasubramaniam et 
al. (2008), botulinum toxin B (BoNT-B) was administered to a patient who presented with 
sustained jaw-opening OMD and also demonstrated immunoresistance to BoNT-A . 
Pharmacological treatments proved to be ineffective for this patient. BoNT-B was administered 
as an experimental treatment after having received all other possible options. BoNT-B had 
demonstrated limited effectiveness in comparison to BoNT-A, and after BoNT-B injections the 
patient suffered low grade fever, mild facial paralysis, and dysphagia that resolved after several 
days. After BoNT-B was proven to be ineffective for this individual, the patient received a lateral 
pterygoid myotomy. The procedure was shown to have relieved all dystonic symptoms and the 
patient remained symptom-free for over 12 months. 
 
1.5 Botulinum Toxin Type A  
 Botulinum toxin (BoNT) is regarded as the most lethal of substances (Jankovic, 2004; 
Simpson, 2004). In the early 1980’s, it was discovered that BoNT-A had applications for medical 
interventions (Dressler & Saberi, 2005). BoNT is produced by bacteria Clostridium botulinum, 
Clostridium baratii, and Clostridium butyricum (Simpson, 2004) and can occur in seven different 
serotypes: A, B, C, D, E, F, and G. All of these serotypes act to inhibit the release acetylcholine 
from nerve terminals; however, they differ in regard to their target proteins and potencies 
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(Dressler & Saberi, 2005). Of the seven existing serotypes, Botulinum toxin type A (BoNT-A) is 
the most studied for medical use and is considered to be an effective treatment for spasticity, 
pain, and focal dystonias including blepharospasm, spastic dysphonia, and cervical dystonia 
(Aoki, 2003; Giladi, 2004; Jankovic, 2004; Snow et al., 1990). BoNT-A is comprised of 
neurotoxins as well as auxiliary non-toxic proteins. The neurotoxin component of BoNT-A can 
be separated into a heavy chain and a light chain, while the non-toxic proteins of BoNT-A are the 
haemagglutinin complex and the non-haemagglutinating proteins (Dressler & Saberi, 2005).  
 Mechanism of action. When the motor neuron depolarizes the axon terminal, 
acetylcholine is released into the synaptic cleft. The release of acetylcholine is produced by the 
soluble N-ethyl-maleimide-sensitive factor attachment protein receptor (SNARE) complex. 
However, when BoNT-A is injected into the target muscle, it binds to the plasma membrane and 
travels across the endosome membrane through receptor-mediated endocytosis (Simpson, 2004). 
Inside the cytosol, the heavy chain docks to glycoprotein structures found on cholinergic nerve 
terminals and the light chain binds to the SNARE complex. BoNT-A specifically cleaves 
synaptosome-associated proteins of 25kDa (SNAP25) of the SNARE complex (Dressler & 
Saberi, 2005). The cleaving action of the light chain prevents docking and fusion of 
acetylcholine vesicles. This results in chemical denervation, paralysis, muscle atrophy, and local 
weakness (Giladi, 1997).  
 When BoNT-A is injected into a striate muscle, the effects have been known to last for 
two to three months (Dressler & Saberi, 2005). When antibodies against BoNT-A are formed, 
noticeable reduction in duration of action and therapeutic effect occur (Dressler & Saberi, 2005; 
Jankovic, 2004). The mechanisms for the development of antibodies are still unknown (Jankovic, 
2004). The variation in duration of effect varies between patients receiving therapy for the same 
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condition (Dressler & Saberi, 2005). If a patient is treated at regular intervals with consistent 
dosage, duration of action is expected to be stable (Dressler & Saberi, 2005).  
 Certain aspects of the mechanism of action of BoNT-A are still poorly understood. 
Evidence suggests that serotype A (BoNT-A) has the most sustained duration of action, although 
the precise cellular mechanism that leads to the termination of action of the toxin is still 
unknown (Simpson, 2004). Additionally, it has been suggested that the mechanism of action of 
BoNT-A treatment may be more complicated than originally hypothesized. One aspect of BoNT-
A therapy that the literature has yet to explain is the apparent dual-phase clinical response to 
BoNT-A treatment: an early response observed within a few hours of injection, and a late 
response which occurs gradually between a period of one to six weeks (Giladi, 1997). Shortly 
after BoNT-A is injected in the target muscle; decrease of miniature endplate potentials (MEPPs) 
is observed (Giladi, 1997). A late response to BoNT-A treatment is also observed in the period 
between the time of BoNT-A injection and the actual clinical improvement which has been 
suggested to vary from one to six weeks or more (Giladi, 1997).  
It is generally understood that the clinical improvement in dystonic symptoms associated 
with BoNT-A treatment is caused by the weakness of the target muscle. However, evidence 
suggests a weak relationship between the actual muscle weakness and beneficial effects (Giladi, 
1997). It has been reported that patients with blepharospasm request reinjection despite 
remaining muscle weakness, citing that spasms and discomfort re-emerge despite remaining 
weakness (Giladi, 1997). Similarly, the observed reduction in pain which takes place before the 
decrease in muscle contractions suggests that BoNT-A treatment has a more complex mode of 
action in managing pain than simply preventing acetylcholine release at the neuromuscular 
junction (Aoki, 2003).  
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1.6 Speech Intelligibility 
Speech intelligibility can be defined as the understandability of speech (Yorkston, 
Dowden, & Beukelman, 1992). It is the correspondence between the message produced by a 
speaker and the percentage of that message correctly understood by the listener (Yorkston, 
Strand, & Kennedy 1996; Schiavetti, 1992). Intelligibility is the single most practical index in 
assessing competence or severity of dysarthric speech because individuals with dysarthria tend to 
assess their disability from a functional perspective (Subtelny, 1977; Yorkston, Beukelman, & 
Bell, 1988; Weismer & Martin, 1992). Speech intelligibility is said to be perfect if the listener 
has correctly identified all of the words deliberately produced by the speaker. In contrast, if the 
listener fails to identify any of the words that the speaker had intended to produce, the speaker 
would have an intelligibility rating of zero. Therefore, speech intelligibility is the measurement 
of interaction between a speaker, a transmission system, and a listener (Schiavetti, 1992). Thus, 
all three components must be taken into consideration to measure speech intelligibility 
(Schiavetti, 1992; Weismer & Martin, 1992).  
1.7 Speech Intelligibility Tasks 
One vital aspect to be considered is how to accurately measure speech intelligibility. 
Intelligibility can be measured across different tasks: phoneme intelligibility, single-word 
intelligibility, sentence intelligibility, and conversational intelligibility.  
Measuring intelligibility in different tasks can provide different kinds of information to 
the researcher or clinician. Phonetic intelligibility testing can provide information about 
intelligibility by identifying the nature of articulatory patterns and types of articulation errors 
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made by individuals with dysarthria (Yorkston, Dowden, & Beukelman, 1992). Phonetic error 
profiles can be generated from specific single word intelligibility tests (i.e., Phonetic 
Intelligibility Test or PIT) (Kent, Weismer, Kent, & Rosenbek, 1989). The phonetic error profile 
which results from this assessment of intelligibility can provide information about phonetic 
contrast errors, and error proportions (Weismer & Martin, 1992). These variables may then be 
used in a regression model to predict intelligibility (Weismer & Martin, 1992). For example, 
Kent and his colleagues (1989) designed a single-word intelligibility task which aimed to 
identify specific speech-related difficulties, to obtain quantitative data to analyze different speech 
features (i.e., vowels, fricatives, stops, etc.), to be sensitive to speech characteristics of different 
clinical populations, and to obtain results that can be related back to other tests of articulation.  
The test words in Kent and colleagues’ (1989) intelligibility test were selected in order to allow 
for the study of 19 phonetic contrasts and acoustic correlates that are believed to impact 
intelligibility. These contrasts are front-back vowels, high-low vowels, long-short vowels, 
voiced-voiceless consonants, alveolar-palatal fricatives, other fricative places of articulation (ex., 
sigh-thigh), fricative-affricate, stop-fricative, stop-affricate, stop-nasal, glottal-null, initial 
consonant-null, final consonant-null, final consonant-null, initial cluster-singleton, final cluster-
singleton, [r]-[l], and [r]-[w]. The Phoneme Intelligibility Test (PIT) (Yorkston, Beukelman, & 
Tice, 1999) is commonly used for measuring phoneme intelligibility. The PIT is administered by 
having listeners select from four options comprised of one target word and three foil words, 
which differ from the target by a single phoneme. Because phoneme intelligibility provides 
information about the types of articulatory errors produced, it may also be beneficial in 
measuring the change in these patterns over time or as a result of intervention (Yorkston et al. 
1992).  
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Measuring intelligibility in single-words can be appropriate for speakers with severe 
dysarthria (Yorkston, Beukelman, & Bell, 1988). These speakers may not be capable of 
conversational speech or the production of longer utterances which are more physiologically 
demanding (Yorkston et al. 1992). Sentence intelligibility provides a more naturalistic speech 
sample and it can also provide information on speech rate as well as intelligibility, which, when 
considered together, can serve as an indicator of an individual’s overall speech efficiency 
(Yorkston et al. 1992; Yorkston et al. 1988). One of the tests most widely used in the dysarthric 
intelligibility literature for measuring both single word and sentence intelligibility is the 
Assessment of Intelligibility of Dysarthric Speech (AIDS; Yorkston & Beukelman, 1981), which 
later became known as the Computerized Assessment of Intelligibility in Dysarthria (CAIDS; 
Yorkston, Beukelman, & Traynor, 1988). Most recently, the Sentence Intelligibility Test 
(Yorkston, Beukelman, & Tice, 2011) has been developed from the CAIDS for measuring 
sentence intelligibility.  
In a landmark study by Yorkston & Beukelman (1978), intelligibility was measured using 
different perceptual tasks for single-words and sentences including transcription, a forced-choice 
paradigm, and sentence completion. Relationships among intelligibility scores of these tasks 
were then measured. It was found that each of the three techniques rank-ordered dysarthric 
speakers in the same way, although the actual intelligibility scores derived from each task varied 
from one another. This suggests that the task of the speakers and the task of the listeners 
contribute to variation in intelligibility scores. More recently, consistent findings have been 
suggested by Kempler & Van Lancker (2002) who provided evidence that the speakers’ task may 
have an effect on their intelligibility. In this study, dysarthric participants with Parkinson’s 
disease were tested on five different speech tasks: spontaneous speech, repetition, reading, 
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repeated singing, and spontaneous singing. It was found that participants were less intelligible 
when producing spontaneous speech.  
While both single word and sentence intelligibility tasks provide measures of an 
individual’s functional ability or severity (Yorkston et al. 1992), neither of these measures is 
capable of providing information as to why intelligibility is so poor, and therefore does little to 
help clinicians develop strategies for improvement of intelligibility.  
Walshe, Miller, Leahy, & Murray (2008) found that individuals with dysarthria had 
different perceptions of their intelligibility compared to their results on a standardized 
intelligibility test (i.e., Assessment of Intelligibility of Dysarthric Speech). This finding 
challenges the validity of using intelligibility scores as a basis for intervention or treatment 
planning, as it has been suggested that evaluation of intelligibility is not comprehensive if the 
therapist neglects to consider perceptions of the client (Walshe, et al., 2008).  
Intelligibility can also be assessed in conversation via the production of spontaneously 
generated speech. The speech sample can be elicited by asking an open ended question and 
allowing the speaker to respond. These conversational or spontaneously generated speech 
samples have the highest face validity compared to phoneme, single-word, and sentence 
intelligibility measures because the majority of everyday communication occurs spontaneously; 
therefore, speech elicited in conversational tasks is the most naturalistic (Kent, Weismer, Kent, 
& Rosenbek, 1989). Conversational speech samples have been used clinically in the assessment 
of intelligibility in dysarthria. For example, the Frenchay Dysarthria Assessment (Enderby, 
1983) measures speech intelligibility using word, sentence, and conversational speech tasks. In 
this assessment, approximately five minutes of spontaneous speech is elicited, and is graded on 
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the following five levels: no abnormality, speech is abnormal but intelligible, speech is severely 
distorted, occasional words are recognizable, and speech is totally unintelligible.  
One potentially valuable aspect of using conversational intelligibility tasks is that the 
context provided in the speech sample has been shown to be beneficial to understanding speech, 
particularly in individuals with mild-moderate dysarthria, because it enables listeners to use top-
down processing to understand a speech sample (Dykstra et al., 2007; Hustad, 2007; Tjaden & 
Wilding, 2011; Yorkston & Beukelman, 1978). Additionally, a vast majority of everyday speech 
occurs conversationally, therefore measuring speech intelligibility using a conversational task 
may provide the most accurate picture of an individual’s intelligibility within the context of 
his/her daily communicative functioning. Although context has been shown to be advantageous 
in individuals with mild dysarthria, Yorkston & Beukelman (1978) found that context provided 
no additional intelligibility benefit to a subset of speakers with very severe dysarthria. It was 
suggested that because the speech signal was heavily degraded in these speakers, the role of 
context was overshadowed. Consistent findings by Hustad (2007) also support this suggestion.  
However, despite the advantages in face validity for conversational tasks, structured speech tasks 
are more widely used in the speech intelligibility literature (Tjaden & Wilding, 2011). This is 
likely because structured tasks enable researchers to provide intelligibility scores with more 
accuracy. In addition, the consistency in content of structured tasks is advantageous in 
comparing findings of different intelligibility studies, and measures between and within speakers 
(Tjaden & Wilding, 2011).  
Aside from the difficulty in comparing findings of different intelligibility studies that use 
conversational speech tasks, there are other challenges in measuring speech in conversation. The 
first challenge relates to objectivity. Since conversational speech is the most naturalistic 
19 
 
 
 
compared to other intelligibility tasks, measuring intelligibility in conversation becomes less 
objective (McHenry, 2011). Conversational speech cannot be measured using objective 
techniques because content is spontaneously created and therefore there is no objective means by 
which to score intelligibility in terms of proportion of words correctly understood. Content in the 
speech sample will vary even if the topic of conversation is the same because individuals are 
asked to generate their own responses. A second challenge relates to the possibility of phonetic 
and phonemic analyses. The analysis of phonemes in conversational tasks becomes problematic 
because of the open nature of responses (Kent et al., 1989). A third challenge relates to severity 
of symptoms. Analysis of conversational speech intelligibility becomes particularly challenging 
in participants with severely impaired speech as these individuals may not be capable of 
producing lengthy utterances. Thus, testing methods that suit certain individuals or types of 
dysarthria might not be appropriate for others (Kent et al., 1989). 
1.8 Measurement of Speech Intelligibility  
Intelligibility can also be measured using different perceptual rating procedures – the 
most common of procedures are direct magnitude estimation (DME), visual analogue scaling 
(VAS) and orthographic transcription.  
Scaling procedures such as DME are considered subjective measures of intelligibility 
(Hustad, 2006) where listeners are asked to provide a rating of various speech parameters in 
order to provide a direct assessment of the qualities of a given speech sample. Direct magnitude 
estimation is a ratio scaling task which does not limit listeners to fit their ratings of intelligibility 
within a set range of values (Schiavetti, 1992). Instead, this procedure allows each listener to rate 
intelligibility as a ratio in proportion to other speech samples in a given set (Schiavetti, 1992). 
20 
 
 
 
DME may be sensitive to other factors that influence speech production, such as voice quality 
and prosody, and may therefore provide a more holistic evaluation of speech production 
(Weismer & Laures, 2002). DME can be completed either with or without a modulus. A modulus 
is an arbitrarily selected speech sample against which subsequent samples are rated 
proportionally (Schiavetti, 1992). Any number can be assigned to a modulus, but 10 or 100 tend 
to be the most commonly assigned value (Schiavetti, 1992).  If a speech sample is considered to 
be more intelligible than the modulus, it would then be assigned a proportionally higher value 
than the modulus. Alternatively, if the speech sample is perceived to be less intelligible than the 
modulus, it will be given an intelligibility rating below the modulus value. The modulus is 
typically chosen to represent midrange speech intelligibility; although, it may also be chosen 
from the lower or higher ranges of intelligibility (Schiavetti, 1992). Careful consideration of the 
modulus is necessary as different moduli can affect intelligibility ratings of a fixed set of speech 
samples (Weismer & Laures, 2002). In the Weismer study (2002), it was found that DME ratings 
were directly influenced by the identity of the modulus, even if all four moduli were considered 
by expert judges to fall within “midrange intelligibility”. This suggests that direct comparison of 
findings of various speech intelligibility studies using a DME paradigm is challenging because 
moduli are rarely ever the same between two studies, and therefore speech intelligibility ratings 
in various studies are likely affected depending on the modulus used (Weismer & Laures, 2002). 
Alternatively, DME can be done without a modulus. This type of procedure is called free-
modulus DME. In this case, the listener is asked to begin with any number to assign to the first 
speech sample, and rate the subsequent speech samples using ratios that represent perceived 
magnitudes of intelligibility (Schiavetti, 1992). A free-modulus paradigm has been suggested to 
be used to prevent interaction between the selected modulus and intelligibility values; however, 
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this has been reported to be both uncomfortable for listeners as well as impractical for 
researchers because resulting intelligibility ratings are not directly meaningful (Weismer & 
Laures, 2002). A free-modulus paradigm has its advantages in that it allows for comparison of 
DME scores across different intelligibility studies (Tjaden & Wilding, 2011). It has been 
suggested that intelligibility ratings from free-modulus DME for structured speech tasks may 
serve as an accurate indication of spontaneous speech in speakers with dysarthria (Tjaden & 
Wilding, 2011) 
VAS is another example of a subjective measure of intelligibility. In VAS, listeners are 
asked to rate a speech sample along a continuum according to how intelligible they perceive it to 
be. Minimum and maximum values along this continuum are fixed; therefore, listeners are 
confined to provide responses within a fixed set of values. A problem with VAS and other 
percentage estimates of intelligibility is that intelligibility scores are not consistent between 
listeners (dos Santos Barreto & Zazo Ortiz, 2008; Yorkston & Beukelman, 1978). In other 
words, there is a large variation of intelligibility scores using percentage estimates, and it is only 
by averaging these individual scores do they resemble the intelligibility values as measured by 
transcription tasks (Yorkston & Beukelman, 1978). These findings are consistent with those of 
Hustad (2006) who found that percentage estimates of intelligibility are not consistent between 
listeners. A notable difference is that Hustad (2006) had also suggested that percentage estimates 
were significantly lower than transcription scores, which differs from Yorkston & Beukelman 
(1978) who found that transcription and percentage estimation lead to intelligibility scores that 
approximate one another.  
It is possible that listeners may be taking into account other important aspects of speech 
production such as speech rate, naturalness, and acceptability while rating a VAS or percentage 
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estimate task. These other aspects of speech production would not be captured by a transcription 
task. Therefore, it is possible that VAS and other percentage estimates provide more holistic 
measures of speech production and intelligibility, while orthographic transcription may primarily 
be sensitive to the articulatory deficit associated with speech disorders. 
Orthographic transcription is an objective measure of intelligibility involving a word 
identification task wherein the listener is asked to write down each word produced by the 
speaker. The transcriptions provided by the listener are then compared to the actual words the 
speaker intended to produce. A percentage of correctly transcribed words is calculated relative to 
the total number of words produced by the speaker. A higher percentage of accurate 
transcriptions correspond to more intelligible speech. The SIT is an example of a test involving 
orthographic transcription, along with the AIDS and CAIDS from which the SIT was derived. 
Additionally, the Phoneme Intelligibility Test (PIT; Yorkston et al., 2011) may be administered 
using a forced-choice paradigm or via orthographic transcription.  
Despite the procedural differences among these measurement paradigms, there is some 
evidence that these different measurement methods can produce similar estimates of 
intelligibility. Tjaden & Wilding (2011) have found moderate correlations between intelligibility 
ratings of free-modulus DME and orthographic transcription tasks. This suggests that these two 
intelligibility measures may be measuring the same construct (i.e., speech intelligibility) in 
similar ways. These findings were similar to those of Yorkston & Beukelman (1978), who found 
that using equal-appearing interval scales and percentage estimates provided similar overall 
intelligibility ratings to those derived from orthographic transcription.  
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1.9 Factors that Impact Speech Intelligibility 
 In addition to procedural differences, other variables must be taken into consideration 
when measuring intelligibility. An example of this is listener’s perception. Hustad (2007) had 
listeners complete confidence ratings in addition to intelligibility measures and it was found that 
listeners tended to underestimate their ability to understand impaired speech. These findings 
were consistent with previous research where listeners’ percentage estimates of intelligibility 
were lower than orthographic transcription scores (Hustad, 2006). A potential explanation for 
this observation was that listeners were not confident in their ability to understand the speech 
samples, so they gave lower estimates (Hustad, 2007).  
Walshe and colleagues (2008) conducted a study investigating factors that affect 
listeners’ perception of intelligibility of dysarthric speech. Specifically, the researchers were 
interested in looking at whether listeners’ experience listening to dysarthric speech and listeners’ 
gender affected their perceptions of intelligibility. No statistically significant gender effects were 
found. Furthermore, strong agreement was found between intelligibility ratings of speech-
language therapists and naïve listeners. This suggests that speech –language pathologists are not 
more critical than naïve listeners, which is somewhat contrary to the findings of Beukelman & 
Yorkston (1980) who stated that speech-language pathologists tend to overestimate intelligibility 
scores in comparison to naïve listeners. It is noteworthy to mention that a potential source of this 
discrepancy is the differences in intelligibility measures used between these two studies. Walshe 
et al. (2008) used a DME paradigm, whereas Beukelman & Yorkston (1980) used a transcription 
task.  
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 Various speech production dimensions have also been examined in regard to their 
relationship with speech intelligibility. De Bodt, Huici, Hernandez-Diaz, & Van de Heyning 
(2002) evaluated the roles of articulation, voice quality, nasality, and prosody, on overall speech 
intelligibility. The authors found that articulation and prosody were the two dimensions with the 
largest contribution to intelligibility.  
1.10 Rationale for the Current Study 
There is currently minimal research investigating speech intelligibility in oromandibular 
dystonia. One of the first studies that examined speech intelligibility in this population was done 
by Dworkin (1996), when testing bite-block therapy on two individuals with Meige’s syndrome. 
Not only did these two participants report functioning at near-normal levels when the bite-block 
was in place, but both participants immediately produced intelligible speech at near-normal 
levels and improved their articulatory precision. A limitation to this study was that exact 
improvements to intelligibility were not quantified objectively. It was only reported by the 
researchers that intelligibility had noticeably improved during use of the bite-block, but the 
specific nature of these improvements were not discussed.  
Dykstra and colleagues (2007) provided preliminary evidence from a case study that 
BoNT-A resulted in improvements in speech intelligibility in an individual with lingual dystonia. 
Lingual dystonia is a type of OMD, where dystonic symptoms are limited to the muscles of the 
tongue. This case study found that BoNT-A was effective in alleviating symptoms of OMD and 
that BoNT-A improved the speech intelligibility of an individual with lingual dystonia. These 
findings form the rationale of the current study. It is hypothesized that BoNT-A may produce 
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differential effects on speech intelligibility in a larger subset of individuals with various 
presentations of OMD. 
 The purpose of this study is to evaluate the speech intelligibility of individuals with OMD 
before and after BoNT-A injections.  
Three main objectives will be examined in this study. These objectives are:  
1. To evaluate differences in speech intelligibility in single-word, sentence, and 
conversational tasks pre- and post-BoNT-A injections. 
2. To compare single-word intelligibility ratings and sentence intelligibility ratings based on 
order of presentation for the single word intelligibility task (words 1-29 and words 30-57) 
and sentence length (5-11 words and 12-15 words) for the sentence intelligibility task. 
3. To evaluate the relationship between orthographic transcription and visual analogue 
scaling intelligibility scores, and to evaluate how single-word, sentence, and 
conversational intelligibility scores relate to one another in OMD. 
It is anticipated that this research will provide preliminary data on the effects of BoNT-A on 
speech intelligibility in individuals with various presentations of OMD and contribute to a small, 
but growing body of research in this field.    
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Chapter 2 
2 Method 
2.1 Participants 
Participants. Ten participants (n=10) diagnosed with OMD were recruited to participate 
in this study. In total there were 6 males and 4 females (age range: 44-80 years; mean age: 66.9 
years), with an average OMD onset of 13.8 years. Participants were recruited from the 
Movement Disorders Clinic, London Health Sciences Centre at London, Ontario and were seen 
by neurologist, Dr. Mandar Jog. These participants were recruited because they were diagnosed 
with OMD, were receiving therapeutic BoNT-A (Botox® or Xeomin®) injections, demonstrated 
reduced speech intelligibility and had no other speech or hearing impairments. Table 1 contains 
specific data for each participant. This table includes information about the participant’s age, sex, 
disease duration, duration of BoNT-A use, frequency of injection, type of OMD, and injection 
sites.  
Table 1. Demographic information of participants with OMD. 
Participant  
ID Sex Age 
OMD 
Duration 
(years) 
Years 
receiving 
BoNT-A 
Frequency 
of injection 
(in months) 
Type of OMD 
Injection site 
and type of 
BoNT-A 
1 M 69 4 3 3  Meige’s (jaw 
closure, lingual) 
orbicularis oris: 
10u total h/s 
(Xeomin®) 
2* F 78 2 3m 3  Jaw opening R&L lateral 
pterygoid: 30u 
total, R&L 
digastric: 40u, 
f/s (Botox®) 
3 F 60 10 8 3 Lingual Genioglossus: 
15u total, R&L 
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digastric: 40u 
total, f/s 
(Botox®) 
4* M 44 3 1 3 Meige’s (labial, 
jaw closure) 
R&L masseter: 
40u total, medial 
pterygoid, 40u 
total, f/s 
(Botox®) 
5 F 69 21 21 3 Lingual, labial, 
jaw closure 
R&L pterygoid: 
30u total, R&L 
digastric: 10u 
total, f/s 
(Xeomin®) 
6 M 78 13 11 3 Labial, jaw 
closure 
Orbicularis oris: 
60u total, R&L 
masseter 40 
units total, f/s 
(Botox®) 
7 M 56 4 4 3 Jaw opening, 
jaw closure, 
lingual 
R&L lateral 
pterygoid: 140u 
total, R&L 
digastric: 40u 
total, tongue: 
30u total, f/s 
 (Botox®) 
8 M 80 23 22 3 Meige’s (jaw 
opening, jaw 
closure) 
R&L lateral 
pterygoids: 120u 
total, R&L 
digastric: 30u 
total, f/s 
(Xeomin®) 
9 M 68 8 3 3 Jaw closure R&L masseter: 
30u total, medial 
pterygoid: 30u 
total, f/s 
(Botox®) 
10 F 67 50 4 3 Meige’s (labial) R&L digastric: 
10u total, R&L 
pterygoid: 20u 
total, f/s, 
orbicularis oris: 
5u, h/s 
(Botox®) 
R = right; L = left; u = units; f/s = full strength; h/s = half strength; * = de-novo 
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 The experimenter explained the nature of the study as well as provided each participant 
with a letter of information (Appendix A) and a consent form (Appendix B) to sign prior to 
participating in the study. Each participant was also informed that they would be asked to return 
for a second visit as a continuation of the study.  Participants provided written consent prior to 
beginning the second experimental session.  This study was approved by the Health Sciences 
Research Ethics Board at Western University (Appendix C). 
Listeners. Five naive individuals (n=5) were recruited to participate in this study as 
listeners. These listeners were undergraduate or graduate level students with a mean age of 21 
years (age range: 20-23 years). All listeners were native English speakers, had no speech, 
hearing, or neurological impairments, and had no familiarity with dysarthric speech or the 
objectives of this research project. Additionally, all listeners passed a 30dB HL hearing 
screening bilaterally at 500, 1000, 2000 and 4000 Hertz (Hz) before participating in the listening 
task. 
2.2 Apparatus 
Speech recordings. Only participants with OMD participated in this part of the study. 
Participants were tested over two sessions: the first experimental session, which will be referred 
to as the “pre-BoNT-A” condition, occurred immediately before participants received their 
routinely scheduled therapeutic BoNT-A injections.  The pre-treatment condition occurred 
approximately three months after participants’ last BoNT-A injections, with the exception of two 
of the 10 participants who were de-novo patients. The second experimental session, which will 
be referred to as the “post-BoNT-A” condition, occurred approximately 4-6 weeks after 
participants received their BoNT-A injections to correspond to peak therapeutic effectiveness 
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(Blitzer & Sulica, 2001).  Each experimental session was comprised of a set of speech 
intelligibility tasks that included single-word, sentence, and conversational intelligibility 
measures.  
 During each experimental session lasting approximately 20 minutes, each participant was 
tested in a quiet treatment room. Each participant wore a headset microphone (AKG C520) to 
record his or her speech. The headset microphone was the primary recording source of obtaining 
measures of speech intelligibility. The microphone was placed 6 cm from the participant’s 
mouth. The microphone was connected to a digital audio recorder (Zoom H4n). This digital 
audio recorder recorded the participant’s speech at a 16 bit and 44 kHz sampling rate.  
Participants were instructed to speak using a natural speaking voice and volume.  
2.3 Materials 
Speech intelligibility tasks. Single-word intelligibility. A measure of single-word speech 
intelligibility was obtained from each participant in both pre- and post- BoNT-A conditions 
using the Phoneme Intelligibility Test (PIT) (Yorkston et al., 2011). The PIT is comprised of a 
list of 57 single words that are randomly generated by a computer program. Each stimulus word 
is one syllable in length and follows a consonant-vowel-consonant (CVC) structure. Each 
participant was required to read a randomly generated word list which was unique from that of 
the other participants. No two participants received an identical word list. The same word list 
was read by participants during the first experimental session (i.e., pre-BoNT-A condition) and 
in the second experimental session (i.e., post-BoNT-A condition) in order to provide an accurate 
measure and comparison of change in intelligibility due to BoNT-A injections. Each participant 
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was instructed to read all 57 words from the PIT presented on a standard 8 ½” x 11” piece of 
white paper in 18 point Times New Roman font (see Appendix D).  
 Sentence intelligibility. Speech intelligibility in sentences was measured using the 
Sentence Intelligibility Test (SIT) (Yorkston et al., 2011). The SIT is comprised of 11 randomly 
generated sentences ranging from 5-15 words in length. Each participant was required to read a 
randomly generated list of sentences unique from the other participants. No two participants 
were assigned the same list of sentences. The same list was read by participants during the first 
experimental session (i.e., pre-BoNT-A condition) and in the second experimental session (i.e., 
post-BoNT-A condition) in order to provide an accurate measure of change in intelligibility due 
to BoNT-A injections. Each participant was instructed to read aloud all 11 sentences from the 
SIT presented on a standard 8 ½” x 11” piece of white paper in 18 point Times New Roman font 
(see Appendix E).  
Conversational intelligibility. Conversational intelligibility was measured by asking each 
participant to talk about a familiar topic for approximately five minutes while being audio 
recorded. The following are examples of questions that were used to elicit conversational speech:  
1. “What do you do for a living?”  
2. “What sorts of hobbies do you have?”  
3. “Tell me about your last vacation?” 
Secondary questions relevant to the original questions were used to encourage further 
conversation from the participants. Each participant was asked different questions in the pre-
BoNT-A and post-BoNT-A conditions. From the five minutes of conversation recorded, each 
participant’s recorded utterances were edited into a single spontaneous conversational excerpt 
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ranging in length from 30-45 seconds in duration. Conversational excerpts were randomized and 
compiled into playlists generated by Windows Media Player that were used as the listener speech 
stimuli. 
All ten participants were asked to complete the three speech intelligibility tasks in the 
same order over both experimental sessions. That is, the SIT was administered first, followed by 
the PIT, and lastly, the conversational speech task.  
Speech sample editing. All speech samples from each intelligibility task (i.e., single-
word, sentence, and conversation) were edited in order to equalize volume to an intensity of 
65dB using Praat (Boersma & Weenink, 2013). Speech samples were randomized and edited into 
playlists consisting of all the single word, sentence, and conversational tokens of each participant 
for both pre-BoNT-A and post-BoNT-A conditions using Windows Media Player.    
Speech recordings from the conversational intelligibility task were edited into excerpts 
lasting 30-45 seconds in duration. Each excerpt was chosen as an exemplar of conversational 
speech containing the least amount of dysfluencies, hesitations, or interruptions. These 
conversational excerpts were used as speech stimuli for the perceptual judgement tasks.  
2.4 Procedure 
 Participants with oromandibular dystonia. Informed consent was first obtained, after 
which each participant with OMD was asked to complete the SIT, PIT, and conversational 
intelligibility tasks while seated comfortable in a quiet treatment room. Each participant was 
informed that he or she would be requested to return for a second testing session 4-6 weeks after 
receiving his/her scheduled BoNT-A injections. During the second testing session, the same 
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three intelligibility tasks were repeated using the same randomly generated lists of single words 
and sentences for each participant. Participants were seated comfortably at a writing desk with 
copies of PIT and SIT tasks placed in front of them. The examiner was seated beside them in the 
testing room during experimental sessions to ensure that set-up of equipment was consistent 
among participants. All participants wore a headset microphone (AKG C520) attached to a 
digital audio recorder (Zoom H4n).  
Listener perceptual judgement tasks. Listening sessions were held in a quiet laboratory 
wherein free-field presentation of speech samples were played at a comfortable listening level 
via M-Audio speakers (AV 40) placed approximately 0.6 metres (24 inches) away from listeners. 
Only the experimenter and the listener were present in the room during each listening session.  
Listeners completed one session in which they perceptually rated speech intelligibility during the 
presentation of participant speech stimuli corresponding to single-word, sentence, and 
conversational intelligibility tasks recorded pre- and post-BoNT-A conditions. For single-word 
(PIT) and sentence intelligibility (SIT) measures, listeners completed two perceptual tasks: 
orthographic transcription and visual analogue scaling. For conversational intelligibility 
measures, listeners completed a visual analogue scaling task only.  
Orthographic transcription:  For the orthographic transcription task, listeners were given 
a pen and paper and orthographically transcribed each speech token (i.e., PIT words and SIT 
sentences) to the best of their ability. An intelligibility score for each participant was determined 
by calculating the percentage of words correctly transcribed by each listener. A mean 
intelligibility score for each participant was calculated by taking the average of each listener’s 
corresponding intelligibility score in either single-word or sentence intelligibility tasks.  The 
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mean intelligibility scores represented either single-word or sentence intelligibility tasks 
measured by orthographic transcription and was used for subsequent statistical analyses.  
Visual analogue scaling: For the visual analogue scaling task, listeners were given a 
response sheet with a line 100mm in length corresponding to each item to be rated. This 100mm 
line had anchors labeled “0% intelligible” on the left and “100% intelligible” on the right side of 
the line (Appendix F). Listeners listened to each speech sample (i.e., PIT single words, SIT 
sentences, conversation) and indicated the level of intelligibility or “understandability” of each 
speech sample by placing an “|” mark along the 100mm line corresponding how intelligible they 
perceived the speech sample to be. “Speech intelligibility” was measured as the distance in 
millimeters from the left end of the scale where the listeners marked an “|” and was expressed as 
a percent (i.e., 83 mm = 83% perceived intelligibility). For the PIT (single-word intelligibility) 
task, listeners provided two VAS ratings: the first rating after presentation of the first half of the 
57 words (words 1-29) and again after the presentation of the second half of the 57 words (words 
30-57). These two VAS ratings were averaged to calculate the overall single word intelligibility 
score. These two VAS ratings were also analyzed separately to determine if there were changes 
in intelligibility due to speaker fatigue.  For the SIT (sentence intelligibility) task, listeners also 
provided two VAS ratings: the first rating after presentation of the first half of the 110 words that 
comprise the SIT (sentences 5-11) and again after the presentation of the second half of the 110 
words (sentences 12-15). These two VAS ratings were averaged to calculate the overall sentence 
intelligibility score. These two VAS ratings were also analyzed separately to determine if there 
were changes in intelligibility due to speaker fatigue or due to the demands of increased sentence 
length. For the conversational intelligibility measure, listeners used visual analogue scaling as 
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previously described above, and judged intelligibility based on a single VAS rating 
corresponding to the single conversational excerpt obtained from each participant.  
 Intelligibility scores for VAS measures were determined according to percent 
intelligibility ratings generated by each listener. A mean percent intelligibility score for each 
participant was calculated by taking the average of each of the five listener’s corresponding 
percent intelligibility score based on single-world, sentence, and conversational tasks. The mean 
percent intelligibility scores obtained via VAS representing single-word, sentence, and 
conversational intelligibility tasks were used for subsequent statistical analyses. 
Order of presentation of intelligibility tasks was counterbalanced across listeners to avoid 
order effects. Within each intelligibility task, order of presentation of speech samples was 
randomized so that no two listeners were presented with speech samples in the same order.   
2.5 Statistical analyses 
 Three objectives were investigated in this study. The first objective aimed to evaluate the 
differences in speech intelligibility based on single-word, sentence, and conversational tasks pre- 
and post- BoNT-A treatment. The second objective  examined  single-word and sentence 
intelligibility in greater detail by comparing intelligibility ratings of words presented in the first 
half of the PIT (words 1-29) with the second half of the PIT (words 30-57) and shorter sentences 
(5-11 words in length) with longer sentences (12-15 words in length). The final objective 
examined relationships among single-word, sentence, and conversational intelligibility scores in 
OMD from orthographic transcription and visual analogue scaling measures. These objectives 
will be addressed using the statistical analyses outlined below. 
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2.5a) Objective 1: Evaluating differences in speech intelligibility based 
on single-word, sentence, and conversational tasks pre- and post-BoNT-
A injection.  
A single-factor repeated-measures MANOVA was conducted. There was one within 
group variable “Time” with two levels [pre-BoNT-A, post-BoNT-A]. Intelligibility scores 
comprised the three dependent variables:  [single-word, sentence, conversation]. Two separate 
MANOVA analyses were conducted. The first analysis was based on visual analogue scaling 
scores. The second analysis was based on orthographic transcription scores. The second analysis 
contains only two dependent variables [single-word, sentence intelligibility] because no 
orthographic transcription measures were obtained for the conversational intelligibility task.  
2.5b) Objective 2: Comparison of single-word and sentence 
intelligibility ratings based on order of presentation of single words and 
sentence length.  
To examine the effect of order of presentation of single words (based on the PIT) and 
sentence length (based on the SIT) on speech intelligibility, a 2-factor repeated measures 
MANOVA was conducted. The within group variables were “Time” and “Order”. “Time” was 
comprised of two levels: [pre-BoNT-A, post-BoNT-A]. “Order” was also contained two levels: 
“First half” represented the first half of the PIT (words 1-29) and the SIT (5-11 words) and 
“Second half” represented the second half of the PIT (words 30-57) and the SIT (12-15 words). 
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The two dependent variables in this analysis were orthographic transcription and visual analogue 
scaling. 
2.5c) Objective 3: Examining the relationships among single-word, 
sentence, and conversational intelligibility scores pre- and post- BoNT-
A.  
For the orthographic transcription intelligibility ratings (expressed as a percentage score), 
Pearson product-moment correlations were calculated in order to examine the relationships 
between the two methods of intelligibility (i.e., single word, sentence) conducted in this study. 
Separate correlational analyses were conducted for the pre-treatment and post-treatment 
conditions. 
For the VAS intelligibility ratings (expressed as a percentage score), Pearson product-
moment correlations were calculated in order to determine the relationships among the three 
methods of intelligibility (i.e., single word, sentence, conversation) conducted in this study. 
Separate correlational analyses were conducted for the pre-treatment and post-treatment 
conditions.  
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Chapter 3 
3 Results 
3.1 Reliability 
Speech intelligibility. Inter-rater and intra-rater estimates of reliability were calculated 
for single-word intelligibility, sentence intelligibility, and conversational speech intelligibility 
measures both before and after BoNT-A injections. Scores from each listener for each 
intelligibility task were measured against each other to obtain inter-rater reliability values. All 
five listeners re-measured 10% of data to determine intra-rater reliability. 
The values obtained for inter-rater reliability ranged from 0.794 to 0.960, p<0.001. These 
correlation coefficients demonstrate overall excellent reliability between listeners for the speech 
intelligibility measures.  Cronbach’s alpha revealed an intra-rater reliability estimate of 0.987, 
p<0.001, which demonstrates high intra-rater reliability for all speech intelligibility 
measurements.  
Table 2 summarizes the intraclass correlation coefficient and Cronbach’s alpha values in 
obtaining overall inter-rater and intra-rater reliability values. Table 3 summarizes the descriptive 
statistics and the results of intraclass coefficient analyses used to obtain inter-rater estimates of 
reliability. Statistical output of the overall inter-rater reliability analysis can be found in 
Appendix G. Statistical output of the overall intra-rater reliability analysis can be found in 
Appendix H.  
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Table 2. Summary of inter-rater and intra-rater estimates of reliability for single-word, 
sentence, and conversational intelligibility tasks. 
 
 Intra-rater reliability Inter-rater reliability 
Intra-class correlation coefficient 
(ICC) 
0.987 
p<0.001 
0.900 
p<0.001 
Cronbach’s alpha 0.987 0.915 
 
Table 3. Summary of inter-rater estimates of reliability for single-word, sentence, and 
conversational intelligibility tasks pre- and post-BoNT-A injections. 
 Listener 
1 
Listener 
2 
Listener 
3 
Listener 
4 
Listener 
5 
ICC Cronbach’s 
alpha 
PIT trans pre1 78.95 75.79 72.98 74.74 80.88 0.948 
p<0.001 
0.961 
PIT VAS pre2 86.25 76.73 56.43 76.05 82.08 0.794 
p<0.001 
0.927 
SIT trans pre3 87.72 85.27 89.55 95.36 96.54 0.906 
p<0.001 
0.940 
SIT VAS pre4 80.08 79.38 72.75 90.93 83.48 0.877 
p<0.001 
0.901 
Conv pre5 75.80 72.75 68.80 87.70 69.30 0.920 
p<0.001 
0.939 
PIT trans post6 79.12 74.56 72.80 75.08 82.63 0.956 
p<0.001 
0.969 
PIT VAS post7 84.23 74.13 70.90 81.53 79.6 0.891 
p<0.001 
0.912 
SIT trans post8 89.18 83.90 90.36 91.54 93.27 0.960 
p<0.001 
0.971 
SIT VAS post9 81.38 78.85 74.20 93.45 76.78 0.893 
p<0.001 
0.928 
Conv post10 74.85 67.05 68.80 91.05 66.70 0.854 
p<0.001 
0.894 
1Single-word intelligibility measured by orthographic transcription pre-BoNT-A.  
2Single-word intelligibility measured by visual analogue scaling pre-BoNT-A.  
3Sentence intelligibility measured by orthographic transcription pre-BoNT-A.  
4Sentence intelligibility measured by visual analogue scaling pre-BoNT-A.  
5Conversational intelligibility pre-BoNT-A.  
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6Single-word intelligibility measured by orthographic transcription post-BoNT-A.  
7Single-word intelligibility measured by visual analogue scaling post-BoNT-A.  
8Sentence intelligibility measured by orthographic transcription post-BoNT-A.  
9Sentence intelligibility measured by visual analogue scaling post-BoNT-A.  
10Conversational intelligibility post-BoNT-A.  
 
3.2   Objective 1: Evaluating differences in speech intelligibility based 
on single-word, sentence, and conversational tasks pre- and post-BoNT-
A injection.  
The primary objective in this study was to investigate whether BoNT-A treatment 
affected intelligibility in single-word, sentence, and conversational speech tasks in individuals 
with oromandibular dystonia. This analysis examined speech intelligibility in single-words using 
the PIT, sentences using the SIT, and in conversation via spontaneous speech recordings. In the 
single-word and sentence intelligibility tasks, intelligibility was measured via orthographic 
transcription and visual analogue scaling techniques. The following analyses were conducted to 
answer the following question: Does BoNT-A treatment result in a change in speech 
intelligibility in participants with various presentations of oromandibular dystonia?  
Based on this objective, the following two comparisons were made: Single-word and 
sentence intelligibility: pre- versus post- BoNT- A treatment (orthographic transcription 
measurement) and Single-word, sentence, conversational intelligibility: pre- versus post- BoNT-
A treatment (VAS measurement). In order to examine the main effect of BoNT-A on speech 
intelligibility, two single-factor repeated-measures MANOVAs were conducted. We used two 
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separate multivariate analyses of variance (MANOVAs) to control for multiple comparison bias 
(Hummel & Sligo, 1971). The first analysis was based on orthographic transcription scores. The 
second analysis was based on visual analogue scaling scores. For both analyses, there was one 
within group variable “Time” with two levels [pre-BoNT-A, post-BoNT-A].  The first analysis, 
using orthographic transcription scores, contained two dependent variables [single-word, 
sentence intelligibility] because no orthographic transcription measures were obtained for the 
conversational intelligibility task. The second analysis, using VAS scores, was comprised of 
three dependent variables:  [single-word, sentence, conversation]. In these analyses, intelligibility 
scores were collapsed across task (PIT, SIT, conversation).   
Orthographic transcription. The first analysis which was based on orthographic 
transcription scores revealed no significant multivariate main effect of “Time” (e.g., pre-BoNT-
A, post-BoNT-A) on speech intelligibility (single-word and sentence tasks) based on 
orthographic transcription, F(2,8)=.381, p=.695, η2partial = 0.087.  
Since no significant multivariate effects were detected, the alpha was adjusted for each of 
the subsequent univariate analyses based on the number of dependent variables (i.e., α/2 = 0.025 
for orthographic transcription). The univariate statistics are presented in Table 4 for orthographic 
transcription. None of these effects are statistically significant at α < .025. Descriptive statistics 
are presented in Table 5. The detailed results of this single-factor repeated-measures MANOVA 
analysis are presented in Appendix I. 
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Table 4. Effect of time on single-word and sentence intelligibility scores measured by 
orthographic transcription. 
 F(1,9) p η2partial  
OT1     
OT – PIT (single words) .022 .920 .001  
OT – SIT (sentences) .725 .417 .075  
1OT: multivariate effect: F(2,8) = .381, p=.695, η2partial = .0875, α/2 = .025 
Table 5: Descriptive statistics of intelligibility scores measured by orthographic 
transcription.  
 
Pre-BoNT-A 
Mean (SD) 
Post-BoNT-A 
Mean (SD) 
OT - PIT (single words) 76.686 (10.859) 76.375 (14.443) 
OT - SIT (sentences) 90.910 (10.397) 89.655 (12.987) 
 
Visual analogue scaling. Similarly, a second single-factor repeated-measures MANOVA 
was conducted in order to examine the multivariate main effect of “Time” on speech 
intelligibility (single-word, sentence, and conversation) as measured by visual analogue scaling. 
This analysis revealed no significant multivariate main effect of “Time” (e.g., pre-BoNT-A, post-
BoNT-A) on speech intelligibility (single-word, sentence, and conversation) based on VAS, 
F(3,7)=.873, p=.499, η2partial = 0.272.  
Since no significant multivariate effects were detected, the alpha was adjusted for each of 
the subsequent univariate analyses based on the number of dependent variables (i.e., α/3 = 0.017 
for VAS). The univariate statistics are presented in Table 6 for VAS measures. None of these 
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effects are statistically significant at α < .017. Descriptive statistics for are presented in Table 7. 
The detailed results of this single-factor repeated-measures MANOVA analysis are presented in 
Appendix J.  
Table 6: Effect of time on single-word, sentence, and conversational intelligibility scores 
measured by visual analogue scaling.  
 F(1,9) p η2partial 
VAS1    
VAS – PIT (single words) .693 .427 .072 
VAS – SIT (sentences) .105 .753 .012    
VAS –  conversation .010 .923 .001 
1VAS: multivariate effect: F(3,7) = .873, p=.499, η2partial = .272, α/2 = .017 
Table 7: Descriptive statistics of intelligibility scores measured by visual analogue scaling. 
 
Pre-BoNT-A 
Mean (SD) 
Post-BoNT-A 
Mean (SD) 
VAS - PIT (single words) 75.5 (12.248) 78.075 (13.595) 
VAS - SIT (sentences) 81.185 (14.932) 80.930 (15.653) 
VAS - conversation 74.870 (21.230) 73.690 (19.087) 
 
Overall, these results, in combination with results of the previous MANOVA using 
orthographic transcription scores, suggests that BoNT-A injections do not produce significant 
changes to speech intelligibility, regardless of how intelligibility is measured (e.g., orthographic 
transcription or VAS).  
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3.3  Objective 2: Comparison of single-word and sentence 
intelligibility ratings based on order of presentation of single words and 
sentence length.  
The purpose of this objective was to evaluate single-word and sentence intelligibility in 
closer detail. Specifically, our aim was to determine if there were any differences in speech 
intelligibility ratings based on order of presentation of single words or difference in speech 
intelligibility based on sentence length.  
A two-factor repeated measures MANOVA was conducted to evaluate differences in 
intelligibility ratings based on order of presentation obtained from the PIT and sentence length 
obtained from the SIT. The two within-subjects factors examined were “Time” which had two 
levels [pre-BoNT-A, post-BoNT-A] and “Order” which also had two levels [first half of words 
and sentences, second half of words and sentences]. There were four dependent variables: PIT 
transcription, PIT VAS, SIT transcription, SIT VAS. Based on this objective, the following 
comparisons were made: Speech intelligibility (orthographic transcription and VAS): first half of 
single-words (1-29) and sentences (5-11 words) vs. second half of single-words (30-57) and 
longer sentences (12-15 words). As before, we used a multivariate analysis of variance 
(MANOVA) to control for multiple comparison bias. No significant multivariate effects were 
detected (for the interaction or either of the main effects), and so the comparison alpha was 
adjusted for each of the subsequent univariate analyses (i.e., α/4 = .0125). These analyses are 
reported within Table 8. 
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Within the univariate effects, there were no significant interactions, but a significant effect of 
“Order” was seen for PIT VAS, F(1,9) = 11.078, p<.0125, η2partial =.552, and for SIT 
transcription, F(1,9) = 11.720, p<.0125, η2partial =.566. SIT VAS approached significance 
within this effect, F(1,9) = 7.499, p=.023, η2partial =.455, but was not statistically significant 
when considering this effect in the context of our adjusted per-comparison alpha. All of these 
univariate effects are also presented in Table 8. Descriptive statistics are presented in Table 9. 
These results suggest that order of presentation of single-words and sentence length has a 
significant effect on intelligibility. Specifically, these results suggest that in a VAS task, listeners 
rate single-words from the first half of the PIT has more intelligible than words presented in the 
second half of the PIT. These results also suggest that listeners rate shorter sentences as more 
intelligible compared to longer sentences in an orthographic transcription task.  
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Table 8: Univariate effects of “Time” and “Order” on single-word and sentence 
intelligibility scores measured by orthographic transcription and visual analogue scaling.  
 F(1,9) p η2partial 
Interaction Effect1    
PIT transcription 2.796 .129 .125 
PIT VAS 4.993 .052 .357 
SIT transcription .001 .974 <.000 
SIT VAS .691 .427 .071 
Main effect of “Order”2    
PIT transcription .511 .493 .054 
PIT VAS 11.078 .009* .552 
SIT transcription 11.720 .008* .566 
SIT VAS 7.499 .023 .455 
Main effect of “Time”3    
PIT transcription .022 .899 .002 
PIT VAS .693 .427 .072 
SIT transcription .717 .419 .074 
SIT VAS 1.623 .235 .153 
1Interaction Effect: F(4,6) = 1.056, p=.453, η2partial = .413, α/4 = .0125 
2Main Effect of “Order”: F(4,6) = 3.342, p=.091, η2partial = .690, α/4 = .0125 
3Main Effect of “Time”: F(4,6) = 1.333, p=.358, η2partial = .471, α/4 = .0125 
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Table 9: Descriptive statistics of single-word and sentence intelligibility scores based on 
“Order” pre- and post-BoNT-A.  
 First half 
PIT words 1-29 
SIT sentences 5-11 
Mean (SD) 
Second half 
PIT words 30-57 
SIT sentences 5-11 
Mean (SD) 
PIT transcription  pre-BoNT-A 75.310 (11.630) 77.990 (10.744) 
PIT transcription  post-BoNT-A 76.253 (14.145) 76.142 (15.834) 
PIT VAS pre-BoNT-A 78.330 (10.233) 72.670 (14.404) 
PIT VAS post-BoNT-A 79.310 (12.135) 76.840 (15.174) 
SIT transcription pre-BoNT-A 93.501 (9.759) 88.222 (11.636) 
SIT transcription post-BoNT-A 92.214 (11.687) 87.000 (14.873) 
SIT VAS pre-BoNT-A 84.420 (13.316) 80.950 (16.688) 
SIT VAS post-BoNT-A 83.150 (13.585) 78.710(17.758) 
 
3.4  Objective 3: Examining the relationships among single-word, 
sentence, and conversational intelligibility scores in OMD.  
This purpose of this objective was to examine potential relationships between intelligibility 
scores based on common measurement techniques used in assessing dysarthric speech 
intelligibility. Specifically, the relationship between VAS and orthographic transcription was 
examined. In addition, this objective examined the relationships among single word, sentence 
and conversational speech tasks in order to identify potential consistencies among speech tasks.   
Therefore, this objective seeks to understand the relationships among different speech 
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intelligibility tasks, and seeks to understand if VAS and orthographic transcription measure 
speech intelligibility similarly in this clinical population.  
In order to determine and to explore these relationships, two Pearson product-moment 
correlations were conducted. The first correlational analysis was for all pre-BoNT-A measures, 
and the second correlational analysis was for all post-BoNT-A measures. For the purposes of this 
study, a correlation value of 0.75 or greater will be considered a strong correlation, 0.50-0.75 
will be considered a moderate correlation, and below 0.50 a mild correlation (Portney & 
Watkins, 2009).  
Pre-BoNT-A. Within intelligibility tasks. A correlational analysis was conducted for pre-
BoNT-A intelligibility measures. It was found that orthographic transcription and visual 
analogue scaling scores were strongly correlated when measuring the same intelligibility task. 
Specifically, strong correlations were found between single-word intelligibility orthographic 
transcription scores (M= 76.650, SD= 10.836) and single-word intelligibility VAS scores (M= 
75.50, SD= 12.248)  (PIT OT and PIT VAS), r = 0.760, p = 0.011 and between sentence 
intelligibility transcription scores (M= 90.909, SD= 10.397)  and sentence intelligibility VAS 
scores (M= 81.185, SD= 14.932) (SIT OT and SIT VAS), r = 0.901, p < 0.001. These results 
suggest that there is a strong relationship between orthographic transcription and visual analogue 
scaling and that these two measurement techniques are likely measuring speech intelligibility in 
a similar way. These results also suggest a strong degree of predictability between transcription 
and VAS scores.  
Within measurement techniques. Additionally, it was found that intelligibility scores of 
different tasks were correlated when measured using the same technique (i.e., orthographic 
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transcription, visual analogue scaling). Strong correlations were found between single-word 
intelligibility transcription scores (M= 76.650, SD= 10.836) and sentence intelligibility 
transcription scores (M= 90.909, SD= 10.397)  (PIT OT and SIT OT), r = 0.753, p = 0.012 and 
between single-word intelligibility VAS scores (M= 75.50, SD= 12.248) and sentence VAS 
scores (M= 81.185, SD= 14.932) (PIT VAS and SIT VAS), r = 0.856, p = 0.002  Furthermore, a 
moderate correlation was found between sentence intelligibility VAS scores (M= 81.185, SD= 
14.932) and conversational intelligibility scores (M= 74.870, SD= 21.225) which was also 
measured by VAS (SIT VAS and CONV), r = 0.639, p = 0.047. These results suggest that VAS 
demonstrates consistency in measuring intelligibility across single-word, sentence, and 
conversational intelligibility and that orthographic transcription is consistent at measuring 
intelligibility in single-words and sentences. These results also suggest that there is a 
correlational relationship between single-word and sentence scores, as well as sentence scores 
and conversational scores when they are measured using the same technique.  
Between intelligibility tasks and measurement techniques. Lastly, correlations were 
found between intelligibility scores across different tasks and different measurement techniques. 
A strong correlation was found between single-word VAS scores (M= 75.50, SD= 12.248) and 
sentence intelligibility transcription scores (M= 90.909, SD= 10.397) (PIT VAS and SIT OT), r 
= 0.808, p = 0.005; and a moderate-strength correlation was found between single-word 
intelligibility transcription scores (M= 76.650, SD= 10.836) and sentence intelligibility VAS 
scores (M= 75.50, SD= 12.248) (PIT OT and SIT VAS), r = 0.728, p = 0.017. These results 
suggest a consistency in intelligibility scores across different tasks (single-word and sentence 
intelligibility) as well across measurement technique (OT and VAS). Taken together, these 
results suggest that significant relationships exist between single-word and sentence 
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intelligibility. These results are represented as a correlation matrix in Table 10. The detailed 
results of this correlational analysis are found in Appendix L.  
Table 10. Pearson correlation coefficients of single-word, sentence, and conversational 
intelligibility measures in the pre-BoNT-A condition.  
 PIT 
transcription 
PIT VAS SIT 
transcription 
SIT VAS  CONV 
PIT 
transcription1 
1 r = 0.760* 
p = 0.011 
r = 0.753* 
p = 0.012 
r = 0.728* 
p = 0.017 
r = 0.444 
p = 0.198 
PIT VAS2 - 1 r = 0.808* 
p = 0.005 
r = 0.856* 
p= 0.002 
r = 0.382 
p = 0.275 
SIT 
transcription3 
- - 1 r = 0.901* 
p = 0.000 
r = 0.389 
p = 0.267 
SIT VAS4 - - - 1 r = 0.639* 
p = 0.047 
CONV5 - - - - 1 
1Single-word intelligibility orthographic transcription score 
2Single-word intelligibility visual analogue scaling score 
3Sentence intelligibility orthographic transcription score 
4Sentence intelligibility visual analogue scaling score 
5Conversational intelligibility visual analogue scaling score 
 
Post-BoNT-A. Within intelligibility tasks. Similarly, a second correlational analysis was 
conducted for post-BoNT-A intelligibility scores. It was found that orthographic transcription 
and visual analogue scaling scores were strongly correlated when measuring the same 
intelligibility task. In this analysis, strong correlations were found between single-word 
intelligibility transcription scores (M= 76.198, SD= 14.618) and single-word intelligibility VAS 
scores (M= 78.075, SD= 13.595) (PIT OT and PIT VAS), r = 0.906, p < 0.05; and between 
sentence intelligibility transcription scores (M= 89.655, SD= 12.986) and sentence intelligibility 
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VAS scores (M= 80.930, SD= 15.653)  (SIT OT and SIT VAS), r = 0.907, p < 0.05. These 
results add support to the previous finding that orthographic transcription and VAS techniques 
measure intelligibility in similar ways and that orthographic transcription and VAS scores are 
predictive of one another.  
Within measurement techniques. It was also found that intelligibility scores of different 
tasks were correlated when using the same measurement technique.  Strong correlations were 
also found between single-word intelligibility transcription scores (M= 76.198, SD= 14.618) and 
sentence intelligibility transcription scores (M= 89.655, SD= 12.986) (PIT OT and SIT OT), r = 
0.756, p = 0.011 and between single-word intelligibility VAS scores (M= 78.075, SD= 13.595) 
and sentence intelligibility VAS scores (M= 80.930, SD= 15.653) (PIT VAS and SIT VAS), r = 
0.899, p < 0.05. Furthermore, a strong correlation was found between conversational 
intelligibility scores (M= 73.690, SD= 19.087) and sentence intelligibility VAS scores (M= 
80.930, SD= 15.653)  (CONV and SIT VAS), r = 0.815, p = 0.004, and a moderate correlation 
was found between conversational intelligibility scores (M= 73.690, SD= 19.087) and single-
word intelligibility VAS scores (M= 78.075, SD= 13.595) (CONV and PIT VAS), r = 0.687, p = 
0.028. These results are consistent with findings in the pre-BoNT-A condition and provide 
evidence that orthographic transcription and VAS techniques measure intelligibility consistently 
across single-word, sentence, and conversational tasks.   
Between intelligibility tasks and measurement techniques. Finally, strong correlations 
were found between intelligibility scores across different tasks and different measurement 
techniques. Strong correlations were found between single-word intelligibility transcription 
scores (M= 76.198, SD= 14.618) and sentence intelligibility VAS scores (M= 80.930, SD= 
15.653) (PIT OT and SIT VAS), r = 0.786, p = 0.007; and between single-word intelligibility 
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VAS scores (M= 78.075, SD= 13.595) and sentence intelligibility transcription scores (M= 
78.075, SD= 13.595) (PIT VAS and SIT OT), r = 0.847, p = 0.002.  Again, these results suggest 
a consistency in intelligibility scores across different tasks (single-word and sentence 
intelligibility) as well across measurement technique (OT and VAS). Taken together, these 
results provide evidence for significant relationships between single-word and sentence 
intelligibility. These results are represented as a correlation matrix in Table 10.  The detailed 
results of this correlational analysis are found in Appendix M.  
Table 11.  Pearson correlation coefficients of  single-word, sentence, and conversational 
intelligibility measures in the post-BoNT-A condition.  
 PIT OT PIT VAS SIT OT SIT VAS  CONV 
PIT OT1 1 r = 0.906* 
p = 0.000 
r = 0.756* 
p = 0.011 
r = 0.786* 
p = 0.007 
r = 0.535 
p = 0.111 
PIT VAS2 - 1 r = 0.847* 
p = 0.002 
r = 0.899* 
p= 0.000 
r = 0.678* 
p = 0.028 
SIT OT3 - - 1 r = 0.907* 
p = 0.000 
r = 0.578 
p = 0.080 
SIT VAS4 - - - 1 r =0.815* 
p = 0.004 
CONV5 - - - - 1 
1Single-word intelligibility orthographic transcription score 
2Single-word intelligibility visual analogue scaling score 
3Sentence intelligibility orthographic transcription score 
4Sentence intelligibility visual analogue scaling score 
5Conversational intelligibility visual analogue scaling score 
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Chapter 4 
4 Discussion  
4.1 Overview 
 This study examined the effect of therapeutic BoNT-A injections on the speech 
intelligibility of 10 participants with various presentations of OMD. Speech intelligibility was 
assessed in single-word, sentence, and conversational speech production tasks. This study also 
examined the differences in speech intelligibility ratings in single-words based on order of 
presentation, as well as in sentences based on sentence length. The final objective of this study 
identified and described the relationships between intelligibility scores measured by orthographic 
transcription and visual analogue scaling techniques and examined relationships among single 
word, sentence and conversational intelligibility tasks. 
 The following sections in this chapter will discuss the primary findings of the present 
study and relate the findings of this study to those of previous research. Subsequent sections will 
discuss the limitations of this study, followed by recommendations for future research. Lastly, 
clinical and research implications will be discussed.  
 The overarching goal of this study was to examine the speech intelligibility of 
participants with oromandibular dystonia in  single-word, sentence, and conversational tasks   
pre- and post- BoNT-A injections in an attempt to gain a better understanding of the impact of 
therapeutic BoNT-A injections on speech intelligibility due to the dysarthria resulting from 
OMD. In order to examine speech intelligibility across various intelligibility tasks, the PIT and 
the SIT created by Yorkston and colleagues (2011), served as the primary measures of 
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intelligibility in single-words and sentences, respectively. Conversational speech generated from 
spontaneous responses to open-ended questions was extracted into 30-45 second samples and 
served as the primary measure of conversational intelligibility.  
4.2 Objective 1: Evaluating differences in speech intelligibility pre- and 
post-BoNT-A injections in single-word, sentence, and conversational 
tasks. 
The first objective of the study investigated the speech intelligibility of participants with 
various presentations of oromandibular dystonia pre- and post-BoNT-A injections.  
Single-word intelligibility. Single word intelligibility was assessed via the PIT. The PIT 
contains 57 single-words, each one syllable and following a CVC pattern. Participants read the 
57 single words aloud while being audio-recorded; the first time before receiving their routinely 
scheduled BoNT-A injections and the second time approximately 4-5 weeks after receiving his 
or her injections to correspond to peak therapeutic effect. Participants were given the same word 
list to read over both testing sessions. Intelligibility was measured using two techniques: 
orthographic transcription and VAS. Non-significant results were found between pre-and post-
BoNT-A single-word intelligibility scores measured by orthographic transcription. Mean 
transcription intelligibility scores before and after BoNT-A injections were 76.65% (SD = 
10.836) and 76.198% (SD = 14.618), respectively. Additionally, non-significant results were 
found between pre- and post-BoNT-A single-word intelligibility scores measured by VAS. Mean 
intelligibility scores pre- and post- BoNT-A injections were 75.5% (SD=12.248) and 78% (SD = 
13.594), respectively. Overall, these results indicate that therapeutic injections of BoNT-A 
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treatment did not result in a statistically significant change to single word intelligibility in our 
participants with OMD regardless of measurement technique.  
Sentence intelligibility. In addition to single-word intelligibility, sentence intelligibility 
measurements were also obtained using the SIT. Participants read aloud 11 unique sentences, 
ranging from 5 – 15 words in length while being audio-recorded; the first time before receiving 
their routinely scheduled BoNT-A injections and the second time  approximately 4-5 weeks after 
receiving his or her  injections to correspond to peak therapeutic effect. Participants were given 
the same unique sentence list to read aloud over both testing sessions. Intelligibility was 
measured using two techniques: orthographic transcription and VAS. Non-significant results 
were found between pre- and post-BoNT-A sentence intelligibility scores measured by 
orthographic transcription. Mean sentence intelligibility scores measured by orthographic 
transcription before and after BoNT-A injections was 90.909% (SD = 10.397) and 89.654% (SD 
= 12.986), respectively. Additionally, non-significant results were found between pre-and post-
BoNT-A sentence intelligibility sores measured by VAS. Mean sentence intelligibility measured 
by VAS before and after BoNT-A injections was 81.185% (SD = 14.932) and 80.930% (SD = 
15.653), respectively. Similar to results at the single-word task, these results suggest that 
therapeutic injections of BoNT-A did not result in a statistically significant change to sentence 
intelligibility in our participants with OMD, regardless of measurement technique (i.e., VAS or 
orthographic transcription). 
Conversational intelligibility. To obtain a measure of conversational intelligibility, 
participants were engaged in approximately 5 minutes of conversation while being audio-
recorded. Thirty to forty-five seconds of spontaneous speech was extracted for analysis. Similar 
to the protocol for obtaining single-word and sentence intelligibility measures, each participant 
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had two testing sessions: before receiving their routinely scheduled BoNT-A injections and again 
approximately 4-5 weeks after receiving his or her injections to correspond to peak therapeutic 
effect.  However, unlike the previous two intelligibility tasks, only VAS measures were obtained 
because there was no way to verify orthographic transcription responses. Non-significant results 
were found between pre- and post-BoNT-A conversational intelligibility scores. Mean 
conversational intelligibility scores before and after BoNT-A treatment was 74.870% (SD = 
21.230) and 73.690% (SD = 19.087). These results indicate that in a conversational intelligibility 
task, therapeutic injections of BoNT-A did not result in a statistically significant change to 
conversational intelligibility in our participants with OMD. 
In this examination of single-word, sentence, and conversational intelligibility, there were 
no significant differences in speech intelligibility ratings of our participants with OMD before 
and after receiving their routinely scheduled therapeutic injections of BoNT-A. This finding is 
contrary to previous research by Dykstra and colleagues (2007) who found that BoNT-A 
injections resulted in a significant improvement in the speech intelligibility in an individual with 
lingual dystonia. Because of the paucity of research relating to the effect of BoNT-A on speech 
intelligibility in this clinical population, it is difficult to ascertain the exact cause of our opposing 
findings, however, possible explanations will be discussed.  
Our sample of participants with OMD was comprised of 6 males and 4 females, each 
with OMD as their primary diagnosis and with no comorbidities. Table 1 presents demographic 
information of participants with OMD. Within our sample, five participants presented with 
mixed dystonia (e.g., jaw and tongue involvement) and five presented with single-site or focal 
involvement (e.g., tongue only, jaw only, lip only). Ideally, a subgroup analysis of speech 
intelligibility based on type and location of OMD (e.g., lingual, jaw opening, jaw closing) would 
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be an interesting analysis to conduct in order to determine if BoNT-A produced differential 
effects to intelligibility based on type or location of OMD. However, due to our modest sample 
size of 10, subdividing participants into smaller and more discrete subgroups would not produce 
statistical results that could be interpreted in an accurate manner. Still, analyzing the effects of 
BoNT-A injections on speech intelligibility based on specific presentation of symptoms is 
warranted in a future study. Previous literature suggests that tongue control is more strongly 
related to speech intelligibility than jaw or lip control in individuals with a neuromotor disorder 
(Weismer, Yusuonva, & Bunton, 2012). Additionally, in previous work examining the efficacy 
of BoNT-A injections on OMD, it has been found that that jaw-opening OMD is less responsive 
to BoNT-A injections than jaw-closing OMD (Tan & Jankovic, 1999; Teive et al., 2012).  
Speech production is unique from other motor movements. It involves a greater variety of 
muscle types than any other motor system (Kent, 2004). Speech also involves the simultaneous 
activation of a greater number of muscle fibers than any other mechanical process (Kent, 2000).  
Smith (2006) conducted a comparison of muscle activity between speech and non-speech tasks 
(e.g., chewing), and suggested that chewing and breathing are controlled by central pattern 
generators which are neural networks in the central nervous system responsible for creating 
patterns of muscle activity necessary for the execution of a motor behaviour. What was observed 
in the muscle activity in a chewing task was clear pattern of simultaneous activation of jaw-
closing muscles such as the masseter, temporalis, and medial pterygoid. The activation of the 
anterior belly of the digastric, a jaw-opening muscle, followed an opposite pattern and only 
occurred during the deactivation of jaw-closing muscles. By contrast, the muscle activity 
involved in speech tasks did not appear to be under the control of central pattern generators. 
Instead of seeing clear activation patterns, a continuous and co-activated pattern of muscle 
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activity was observed. Notably, there was very little activation of the masseter and temporalis 
muscles during speech, as is expected because there is less jaw movement in speech production 
than there is in chewing. The muscles involved jaw-opening and closing for speech movements 
were the anterior belly of the digastric and medial pterygoid, respectively. This suggests that the 
motor movements involved in speech and non-speech tasks are managed by different neural 
mechanisms. The notion that speech and non-speech tasks are facilitated by different neural 
mechanisms is consistent with other findings (Ruark & Moore, 1997). Additionally, Weismer 
(2006) has provided arguments against the use of non-speech oromotor tasks as a measure of 
motor speech control. Although speech and non-speech tasks are executed by a similar set of 
muscles, they differ in patterns of muscle control and nature of muscle movement (Weismer, 
2006). It has even been suggested that the neural mechanisms responsible for two different 
verbal tasks, speech and singing, are unique from one another (Kent, 2004). The difference in 
underlying neural mechanisms of these oromotor tasks could be a reason dystonic symptoms 
such as severity and frequency of spasms, involuntary movement, and pain were improved due to 
BoNT-A injections as seen in previous literature (Cultrara et al., 2004; Esper et al., 2010; Teive, 
et al., 2012), but that these improvements were not extended to speech intelligibility outcomes in 
the present study.     
The motor speech disorder associated with OMD, hyperkinetic dysarthria, is primarily 
characterized by imprecise consonant articulation, vowel distortion, and irregular articulatory 
breakdown (Darley, Aronson, & Brown, 1969). In general, dysarthrias are known to have global 
impacts on speech and can produce many effects on speech production such as intelligibility, 
prosody, voice quality, and speech rate (Kent, 2000). Some of the findings in the present study 
may be reflecting the different dimensions of speech production aside from intelligibility that are 
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affected by hyperkinetic dysarthria. Specifically, in comparing orthographic transcription and 
visual analogue scores for sentence intelligibility in the present study, it was found that VAS 
intelligibility scores were much lower than transcription scores. Mean sentence intelligibility 
scores measured by VAS pre- and post-BoNT-A were 81.185% and 80.930%, respectively. 
Mean sentence intelligibility scores measured by transcription pre- and post-BoNT-A were 
90.909% and 89.654%, respectively. However, in single-word intelligibility tasks, these 
differences are less consistent. Mean single-word intelligibility scores measured by VAS pre- 
and post-BoNT-A were 75.5% and 78%, respectively. Mean single-word intelligibility scores 
measured by transcription pre- and post-BoNT-A were 76.65% and 76.198%, respectively. The 
lower VAS scores in sentence intelligibility may be reflecting other aspects of speech production 
affected by hyperkinetic dysarthria such as naturalness, listener effort, and acceptability, which 
can impact intelligibility scores. These patterns were not reflected in the single-word tasks 
because presenting listeners with individual words one at time likely did not provide an overall 
impression of these other aspects of speech production that may contribute to intelligibility. It 
seems as though VAS measures were likely providing a more holistic measure of intelligibility in 
comparison to transcription, which was likely only sensitive to articulation. This interpretation 
may be supported by Yorkston, Beukelman, and Traynor (1988) who suggested that measuring 
articulatory deficits alone does not provide an indicator of overall speech adequacy. Because of 
the multidimensional effects of hyperkinetic dysarthria on speech production, it is possible that 
treatment via BoNT-A injections may not be addressing all of the irregularities in speech 
production exhibited by participants.   
It has been suggested that dysarthrias caused by chronic conditions, as is the case in the 
current study, cannot be completely cured or resolved by medical intervention (Kent, 2000). 
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Therefore, relying on BoNT-A treatment exclusively to reduce speech-related deficits caused by 
OMD may not be an entirely realistic expectation. The treatment of OMD using BoNT-A 
injections is to primarily improve involuntary dystonic muscles contractions and manage pain 
(Cultrara et al., 2004; Esper et al., 2010; Teive et al., 2012), not to improve specific speech-
related outcomes.  Although there is no available cure for OMD, behavioural therapy may be 
helpful in the management of dystonic symptoms that impair speech intelligibility (Yorkston, 
1996). Common behavioural interventions for dysarthria include, but are not limited to, 
articulation exercises, breath control exercises, rate control exercises, and use of a pacing board 
(Yorkston, 1996). There is also a demand for a combination of both behavioural and medical 
interventions; however, the efficacy of combining interventions has not been empirically 
examined and are thus still poorly understood (Kent, 2000). Furthermore, by combining 
behavioural interventions with BoNT-A treatment, the management of dystonia and its related 
symptoms can be customized to each individual based on the subtype of OMD with which they 
present as well as the severity of symptoms.  
4.3 Objective 2: Comparison of single-word and sentence intelligibility 
ratings based on order of presentation of single-words and sentence 
length.  
A two-factor repeated measures MANOVA revealed a significant main effect of the order 
of presentation of single-words where listeners rated the first half of words on the PIT (words 1-
29) as more intelligible than those in the second half of the PIT (words 30-57). The same two-
factor repeated measures MANOVA revealed a significant main effect of sentence length on 
intelligibility in our participants. More specifically, shorter sentences (5-11 words) were rated as 
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more intelligible than longer sentences (12-15 words) based on the SIT. These results were 
consistent across conditions (i.e., pre-, post-BoNT-A), suggesting that the effect of “Order” is 
more likely due to OMD itself, rather than the result of receiving BoNT-A injections.  
These findings may be explained by a speech fatigue effect in speakers. Speakers were 
not given any breaks between the recording of the first and second half of the PIT or the SIT. It 
is possible that when the end of each intelligibility task was reached, participants’ speech 
production mechanisms became fatigued which aggravated their dystonic symptoms and lead to 
a decrease in speech intelligibility ratings for the second half of words on the PIT and for longer 
sentences on the SIT. In the single-word intelligibility task, the protocol involved having 
participants read individual words in the order that they were presented on the list. In the 
sentence intelligibility task, the protocol involved having participants begin reading shorter 
sentences that progressed in length. Because there was an observed effect based on order of 
presentation and sentence length on intelligibility scores, it is possible that speakers exhibited a 
fatigue effect which impacted their speech intelligibility. These findings may supported by those 
of Dworkin & Aronson (1986) who found that dysarthric subjects who exhibited tongue 
weakness also demonstrated articulatory difficulties. More recently, in an attempt to determine 
the impact of fatigue on speech production, Solomon (2000) induced fatigue of tongue muscles 
in neurologically normal individuals and found that induced fatigue reduced speech precision 
and even after a recovery period, participants were still not able to perform speech tasks at a 
baseline level. Although limited data is available regarding the endurance or fatigue of dysarthric 
subjects during speech production, Kent, Kent, and Rosenbek (1987) have noted the potential 
clinical importance of determining maximum performance particularly in individuals with 
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neurologic disorders as a step towards the identification of reduced speech production capacity. 
A reduced speech production capacity may make speech a demanding process.  
The significant effect of sentence length in our results is consistent with previous 
literature (Ansel & Kent, 1992) that suggests that utterance length is a factor that influences 
intelligibility. A possible explanation for these results is that shorter utterances are more 
beneficial to the listener. More specifically, shorter utterances contain syntactically simpler 
sentence patterns making them more easily understood. This could aid the listener in using 
semantic information from the sentences and filling in words that were less intelligible. Longer 
sentences are more syntactically complex and therefore it becomes more challenging to take 
advantage of these semantic cues to increase predictability of the sentence. The SIT task 
provides listeners with semantic information which has been shown to increase intelligibility, 
particularly in speakers with mild to moderate dysarthria. The effect of these semantic cues may 
have been observed in the results of the present study. Specifically, it has been suggested that 
semantic cues in sentences increase the predictability of the utterance and therefore make use of 
top-down processing instead of relying on the acoustic signal to determine intelligibility 
(Yorkston, Strand, & Kennedy, 1996; Yorkston & Beukelman, 1981).  In shorter utterances with 
simple syntactic structures, such as the SIT sentences with 5 – 11 words, it may be easier for 
listeners to take advantage of semantic information to increase the predictability of the words in 
each sentence and make use of top-down cognitive processing. Longer sentences which are 
syntactically more complex, such as SIT sentences with 12-15 words in length, are semantically 
more difficult to predict, therefore listeners may have found it more challenging to use semantic 
content in filling spaces in sentences that were difficult to understand and would have to depend 
more strongly on the acoustic signal itself. Additionally, in cases where speakers have more 
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severely disordered speech, the majority of the utterance may have been difficult to understand, 
creating greater challenges for listeners to use top-down processing to compensate for a weak or 
degraded acoustic signal.  
Aside from semantic and syntactic differences that aid the listener, another potential 
explanation for the discrepancy in intelligibility ratings between shorter and longer sentences is 
that shorter sentences may be more beneficial for the speaker. Producing shorter sentences 
requires less energy and effort for speakers, and therefore is a less demanding speech production 
task in comparison to tasks involving the production of longer sentences. Longer sentences may 
be more taxing to the speech production mechanism and therefore may be more challenging for 
speakers with dysarthria to produce. If this is the case, increasing the speech demands of 
participants may have enabled us to gain some insight on the extent of the impact of OMD on 
speech intelligibility.  
Another factor that might have affected results in the present study is the time of day 
when speech samples were recorded. Many participants informally shared with the experimenter 
that their speech was generally worse in the afternoons and evenings. Most of the speech sample 
recordings occurred in the afternoon. This anecdotal evidence may lend support to the suggestion 
of a fatigue effect and exacerbation of dystonic symptoms which may have led to a decrease in 
intelligibility.  
Listener fatigue, or the phenomenon in which listeners can become fatigued from 
transcribing disordered speech, was controlled for by the  counterbalanced presentation in which 
listeners were asked to rate the speech samples. Three of the five listeners were asked to rate the 
speech samples from shortest sentences to longest sentences, which was also the order in which 
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the sentences were recorded. The remaining two of the five listeners were presented with speech 
samples that had shorter and longer sentence groups reversed. In other words, these listeners 
were presented with sentences that were 12-15 words in length first and were subsequently 
presented with the shorter sentences of five to eleven words in length. The two listeners who 
began with the longer sentences gave intelligibility ratings that were consistent with that of the 
three listeners who began with the shorter sentences, therefore suggesting that listener fatigue 
was not an explanation as to why longer sentences consistently received lower intelligibility 
ratings.  
4.4 Objective 3: Examining the relationships among single-word, 
sentence, and conversational intelligibility scores in OMD. 
The final objective of this study sought to determine how intelligibility scores derived 
from different measurement techniques are related to one another and how different intelligibility 
tasks (i.e., single-word, sentence, conversational) are related to one another. Relationships were 
examined in the pre- and the post- BoNT-A conditions. 
In both pre- and post-BoNT-A conditions, statistically significant correlations were found 
between orthographic transcription and visual analogue scaling scores when measuring the same 
intelligibility task. Specifically, significant correlations were found between single-word 
intelligibility transcription scores and single-word intelligibility visual analogue scaling scores, 
as well as between sentence intelligibility transcription scores and sentence intelligibility visual 
analogue scaling scores. These findings suggest that orthographic transcription and visual 
analogue scaling are measuring intelligibility in a similar way. These findings also suggest that 
orthographic transcription measures and VAS technique scores are statistically reliable in 
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measuring intelligibility and are predictive of one another. This finding may be supported by 
previous work that suggests that intelligibility estimates, when averaged, reflect transcription 
scores (Yorkston & Beukelman, 1978). Additionally, in both pre- and post- BoNT-A conditions, 
strong correlations were found between intelligibility scores of different tasks when measured 
using the same technique. Specifically, strong correlations were found between single-word 
intelligibility transcription scores and sentence intelligibility transcription scores, as well as 
between single-word intelligibility visual analogue scaling scores and sentence intelligibility 
visual analogue scaling scores. Lastly, statistically significant correlations were found between 
different intelligibility tasks and different measurement techniques in both pre- and post- BoNT-
A conditions. Specifically, statistically significant correlations were found between single-word 
intelligibility transcription scores and sentence intelligibility visual analogue scaling scores, as 
well as between single-word intelligibility visual analogue scaling scores and sentence 
intelligibility transcription scores. This suggests that the correlational relationship between 
single-word and sentence intelligibility tasks remains regardless of measurement technique used. 
Additionally, it provides further evidence of the reliability between single-word and sentence 
intelligibility scores (Tjaden & Wilding, 2011). These findings also support findings of Yorkston 
& Beukelman (1978) who did not find significant differences between single-word and sentence 
intelligibility scores measured by transcription.  
 Conversational intelligibility scores appear to have a less consistent relationship with 
single-word and sentence intelligibility. A statistically significant correlation was found between 
sentence intelligibility visual analogue scaling scores and conversational intelligibility scores, in 
both pre- and post-BoNT-A conditions, which provides further evidence of the consistency of 
intelligibility scores when measured by the same technique. However, no correlations were 
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found between sentence intelligibility transcription scores and conversational intelligibility 
scores or between single-word intelligibility transcription scores and conversational intelligibility 
in both pre- and post- BoNT-A conditions. A simple explanation for this finding may be that the 
speech production task of the speaker influences intelligibility scores. For example, it was found 
that spontaneous speech has significantly lower intelligibility than read or repeated speech 
(Kempler & Van Lancker, 2002). Another  possible explanation for the non-significant 
correlational relationship of other speech intelligibility measures with conversational speech is 
that participants were given material to read in the single-word and sentence level tasks, but for 
conversational intelligibility, spontaneous speech was elicited by asking participants an open-
ended question (i.e., What do you do for a living?). Perhaps single-word and sentence 
intelligibility demonstrated stronger correlations because external models or cues (e.g., read 
speech) were provided which were not provided in the conversational speech condition (e.g., 
spontaneous speech).  External models decrease the demand placed on basal ganglia with regard 
to the planning and execution of motor speech movements (Kempler & Van Lancker, 2002). 
Furthermore, not only was there a difference in that external models were provided for single-
word and sentence tasks and not for the conversational task, but also there was a difference in the 
measurement technique used to obtain these scores. The difference in measurement technique 
(transcription for PIT and SIT, VAS for conversation) may also be a contributing factor to the 
non-significant correlation and may also lend support to the notion that VAS may be capturing 
other aspects of speech production, such as speech rate, prosody, and voice quality, that 
transcription does not account for.   
A final possible explanation for the inconsistency of conversational intelligibility results 
is that differences in intelligibility score are emphasized when the content of the speech samples 
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differ (Tjaden & Wilding, 2011). The material used to evaluate sentence and conversational 
intelligibility, which both measure intelligibility of connected speech and make use of contextual 
information, were inherently different because participants were free to choose whatever words 
they wanted to in the conversational condition. Additionally, conversational speech was elicited 
using different questions, therefore making the content of the two speech samples different in the 
pre-BoNT-A and post-BoNT-A conditions. In the single-word and sentence intelligibility tasks, 
participants were asked to read identical material for both treatment conditions.  Furthermore, 
these findings are consistent with published studies (Tjaden & Wilding, 2011) that suggest that 
intelligibility scores derived from validated clinical intelligibility tests cannot be extrapolated to 
spontaneous speech.  
4.5 Limitations of the Current Study  
Although this study revealed some interesting findings, it is important to acknowledge 
some of its methodological limitations. The first methodological limitation relates to the sample 
size of the current study. The current study examined the speech intelligibility of 10 participants 
with various subtypes of OMD. This is mainly due to difficulties in participant recruitment. The 
prevalence of OMD is estimated to be only 68.9 cases/million persons (Nutt, Muenter, Aronson, 
Kurland, & Melton, 1988). Further, the eligibility criteria for this study involved participants to 
have primary OMD without any other comorbidities, making data collection in this population 
particularly challenging. Because of the modest sample size and number of comparisons in our 
analysis, the current study is likely underpowered. Additionally, the ability to generalize findings 
is limited. Furthermore, the small sample size prevents further investigation into the differential 
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effects of BoNT-A injections on speech intelligibility based on the various types/presentations of 
OMD (e.g., jaw opening, jaw closing, lingual, labial, mixed). 
The second limitation relates to the participants BoNT-A injection schedule and the 
relationship to baseline intelligibility scores. Eight out of 10 participants received BoNT-A 
injections on a 3-4 month cycle (the remaining two participants were de-novo). The pre-BoNT-A 
condition corresponded to the final day of each participant’s 3-4 month injection cycle. It was the 
intention that we were seeing participants when BoNT-A had worn off, however, there was no 
definitive way to determine with certainty that the effects of the previous BoNT-A treatments 
had diminished completely prior to the next series of injections. Therefore there remains some 
uncertainty about the baseline intelligibility measurements in the pre-BoNT-A condition. 
Although the treatment schedule followed by participants in the current study is consistent with 
previous literature (Tsui, 2005), suggesting that BoNT-A treatments follow a 3-4 month cycle, a 
future study may seek to extend the injection cycle to 6 months or more to ensure that BoNT-A 
had a complete “wearing off” effect before obtaining baseline intelligibility measures.  
The third limitation relates to the history of BoNT-A treatment of each participant. Only 
two out of 10 participants with OMD were de-novo. The remaining eight participants had been 
receiving ongoing therapeutic injections of BoNT-A during the data collection period of the 
current study. Because of this, the speech samples obtained for the pre- and post-BoNT-A 
conditions is merely a snapshot of their progress throughout the course of their treatment and not 
a comprehensive look at how their speech production has been impacted by BoNT-A throughout 
the history of their treatment for OMD. Therefore, measuring speech intelligibility before and 
after receiving a single series of BoNT-A injections may have resulted in the limited change in 
speech intelligibility observed in the results of the current study. This also relates to the second 
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limitation involving the difficulty in ascertaining that the effects of the previous BoNT-A 
injections had completely diminished prior to collecting baseline speech recordings. Because the 
majority of participants had received BoNT-A injections before the inception of this study, the 
speech samples obtained from these participants may not be a true representation of their speech 
production pre-injection. As a result, there the possibility remains that the residual effects of 
previous treatment were present during the recording of the baseline speech samples.  
Finally, the fourth limitation of this study relates to the artificial nature of speech 
recording that is inherent to clinical intelligibility testing. Although we made an attempt to elicit 
an ecologically valid estimate of speech intelligibility (i.e., the conversational intelligibility task), 
the recorded speech was collected in a room with no background noise. Our daily conversations 
rarely occur in complete silence. This could mean that speech recorded in a quiet clinical 
environment may be produced differently than true day-to-day conversational speech. Therefore, 
the ability to generalize findings from this study to a real-life setting is limited. Because only 30-
45 seconds of spontaneous speech was elicited for this speech task, there is no sufficient 
evidence to verify that the proposed fatigue effect observed in the sentence intelligibility tasks 
carried over to conversational speech. A conversational speech sample of 30-45 seconds in 
duration may not be adequate to tax the speech production mechanism to determine if speech 
intelligibility changes with sustained speech production over time, potentially due to fatigue.  
4.6 Future Directions 
The results of the current study provide information and rationale from which further studies 
can be developed. Further exploration in this area can be pursued by adapting the research design 
to examine results in greater depth.  
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 The present study intended to study the effects of BoNT-A treatments on the speech 
intelligibility of individuals with various presentations of oromandibular dystonia. The current 
study tested participants before and after a single series of BoNT-A injections and examined 
differences in speech intelligibility between these two testing conditions. A valuable future 
investigation would be to follow up with participants over a longer period of time beyond the 
four to six week period used in the current study. A longitudinal approach such as this would 
allow researchers examine speech intelligibility in more detail to determine potential variability 
in speech intelligibility over the course of a treatment cycles.  Tan & Jankovic (1999) conducted 
a prospective clinical trial of 162 individuals diagnosed with OMD with a mean follow up period 
of four years wherein the researchers examined the effects of botulinum toxin A in OMD 
participants and found that botulinum toxin A treatment caused a significant improvement in 
both the severity of dystonia and the function of the affected areas. However, the researchers did 
not appear to measure specific speech-related outcomes that would be relevant to the line of 
research addressed by the current study. A longitudinal approach has not currently been 
conducted in the examination of speech intelligibility and other communication-related outcomes 
in a population with OMD. This approach could potentially provide valuable information to 
supplement the findings of the current study. If results from longitudinal research determined 
that BoNT-A injections did improve speech intelligibility over time, this would provide a 
stronger rationale for the continued use of BoNT-A for individuals with OMD and associated 
dysarthria. However, if the results were consistent with that of the current study, it may challenge 
the clinical utility of BoNT-A injections for individuals with OMD whose foremost priority is to 
improve their intelligibility. Perhaps in this case a more appropriate approach to therapy would 
entail a combination of behavioural and medical intervention, as suggested by Kent (2000). It 
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would also be important to solicit feedback from each patient to determine if BoNT-A had a 
perceived beneficial effect for their dystonia and speech production. 
 In addition to expanding this research longitudinally, it would be interesting to replicate a 
future study with a larger number of participants. Having a greater sample size would allow for a 
more in-depth analysis of the effect of BoNT-A injections on speech intelligibility in OMD 
based on type and presentation. This information would be important in adding to the limited 
empirical research on the effects of BoNT-A injections on speech intelligibility, which is of 
scientific and clinical value. It would also be interesting to replicate this study using de-novo 
participants only. Testing participants at the start of their treatment and capturing the effects that 
BoNT-A has on speech intelligibility may produce compelling results. If future research finds an 
improvement in speech intelligibility in de-novo participants that is not present in participants 
who had been receiving BoNT-A injections prior to the collection of speech samples, these 
findings may suggest a cumulative improvement in intelligibility over the course of treatment. 
Therefore, although it may appear that individuals receiving ongoing BoNT-A injections are not 
deriving a benefit to speech intelligibility, it may be the case that there was a significant change 
to speech intelligibility at the beginning of treatment which has since plateaued and is no longer 
affected by subsequent BoNT-A injections. 
Using more naturalistic approaches such as recording speech samples in background 
noise or by adapting the design of the study wherein both participant and listener are tested 
together allowing for natural communicative interactions could also lead to some interesting 
insights on the effectiveness of BoNT-A injections on speech intelligibility. Furthermore, 
comparing intelligibility ratings of listeners based on familiarity (i.e., naïve listeners vs. 
caregivers) before and after BoNT-A injections may produce important results. Previous work 
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has suggested that speaker experience and listener familiarity impacts intelligibility scores 
(Ansel & Kent, 1992; Tjaden & Liss, 1995a; Tjaden & Liss, 1995b). It is possible that familiar 
listeners may be more sensitive than naïve listeners at identifying subtle differences in 
intelligibility after treatment.  
 Another possible direction for this line of research is to measure qualitatively the impact 
of BoNT-A injections in speech intelligibility and communicative ability in this population. If it 
was found that BoNT-A injections improved participants’ perception of their speech 
intelligibility or communicative abilities, this could justify the continued use of this therapeutic 
option. It would also be important to look holistically at the overall impact of BoNT-A 
injections. This information could help to determine the overall benefit in the management of 
other dystonic symptoms such as pain and uncontrollable muscle contractions (Jankovic, 2006) 
and managing orofacial esthetics (Bhattacharya & Tarsy, 2001), for example. Previous literature 
has demonstrated that BoNT-A injections in OMD can improve quality of life and help manage 
dystonic symptoms  (Bhattacharyya & Tarsy, 2001; Dykstra, Adams, & Jog, 2007; Tan & 
Jankovic, 1999; Teive et al., 2012). Perhaps future research can address the impact of BoNT-A 
treatment on communication-related quality of life and communicative participation in this 
population. If findings of this future research are positive, perhaps this could imply that there are 
other aspects of communication beyond intelligibility that BoNT-A treatments are effective at 
improving.  
 Finally, measuring listener effort in relation to speech intelligibility may lead to 
interesting findings. Previous research has suggested that listener effort is sometimes included in 
definitions of intelligibility, although listener effort and intelligibility should be regarded as 
separate constructs (Whitehill & Wong, 2006). It would be interesting to examine how listener 
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effort, which can be measured via VAS, are related to intelligibility scores measured by both 
VAS and orthographic transcription techniques.  
4.7  Research and Clinical Implications 
  The results of this study adds to the small but growing body of empirical literature on 
speech intelligibility in oromandibular dystonia and also provides preliminary data on how 
BoNT-A injections can effect speech intelligibility in individuals with oromandibular dystonia. 
Developing an understanding of how speech intelligibility is impacted by dystonic symptoms of 
OMD and BoNT-A injections is essential since BoNT-A is the most widely used treatment for 
OMD (Jankovic, 2006). If individuals with OMD prioritize the improvement of their speech 
intelligibility, then it is important to know what the best course of treatment is to ensure optimal 
communicative outcomes. With continued systematic and empirical study in this area of 
research, future studies can inform novel assessment and treatment protocols for the 
improvement of speech intelligibility in OMD.  
4.8  Summary and Conclusions 
 This study was designed to evaluate the effects of BoNT-A injections on speech 
intelligibility in oromandibular dystonia by measuring speech intelligibility in single-word, 
sentence, and conversational tasks before and after participants received therapeutic BoNT-A 
injections. In addition to this research objective, the relationships among intelligibility scores in 
single-word, sentence, and conversational intelligibility tasks, and relationships between 
orthographic transcription and visual analogue scaling techniques in pre- and post-BoNT-A 
conditions were explored.  
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 The first objective of this study revealed no significant differences between speech 
intelligibility scores for single-word, sentence, and conversational tasks before and after 
receiving BoNT-A injections, regardless of whether intelligibility scores were measured by 
orthographic transcription or visual analogue scaling. These results suggest that BoNT-A 
injections do not affect speech intelligibility, either positively or negatively.  
 The second objective of this study revealed that in the single-word intelligibility task, 
listeners rated single-words on the first half of the Phoneme Intelligibility Test as more 
intelligible than the second half of the test. Stated differently, single words that participants with 
OMD recorded first resulted in higher intelligibility scores than the latter half of single words of 
contained on the PIT. In addition, listeners rated shorter sentences (5-11 words in length) as 
more intelligible than longer sentences (11-15 words in length) based on the SIT. This 
statistically significant difference was present in VAS scores, and was trending towards 
significance in orthographic transcription scores. Taken together, these results suggest that as 
speech tasks become more demanding, dystonic symptoms are exacerbated which negatively 
impacts speech production. These results also suggest the possibility of a fatigue effect which 
becomes more pronounced as utterances are lengthened or when the motor demands of speech 
production have increased.  
 Finally, the third objective of this study revealed significant correlational relationships 
between single-word and sentence intelligibility scores as measured by orthographic 
transcription and visual analogue scaling techniques. Additionally, significant correlations were 
found between sentence intelligibility scores measured by visual analogue scaling as well as 
conversational intelligibility scores, which were also measured via visual analogue scaling. 
However, the relationship between conversational intelligibility scores and that of single-words 
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is not significant; and the relationship between conversational intelligibility and sentence 
intelligibility is not consistent. More specifically, conversational and sentence intelligibility are 
only correlated when both tasks are measured using the same technique, which supports the idea 
that VAS measures are sensitive to aspects of speech production, such as speech rate, 
naturalness, and acceptability, that transcription measures do not capture. When sentence 
intelligibility is measured using orthographic transcription, no correlations with conversational 
intelligibility are revealed. Two  possible explanations for this is that external cues are present at 
the single-word and sentence levels, but are not present at the conversational level (i.e., where 
participants have to generate the semantic content of their speech sample) and that the 
neurological mechanisms facilitating the production of read speech and spontaneous speech are 
different.  
 This study has revealed novel and potentially valuable information in the study of speech 
intelligibility in oromandibular dystonia. The results and implications of this research can serve 
as basis upon which to design future research that investigate the role of BoNT-A in the 
improvement of speech intelligibility in this population. With further exploration, this 
information has the potential to contribute to our knowledge of speech intelligibility in 
oromandibular dystonia. Lastly, the findings from this line of research will contribute to a small 
but growing body of literature regarding the effect of BoNT-A injections on speech intelligibility 
in oromandibular dystonia.  
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APPENDIX A 
Letter of Information 
STUDY TITLE 
The effects botulinum toxin A on speech intelligibility, levels of speech usage, communication 
apprehension, self-perceived communication competence, communicative effectiveness, communication-
related quality of life and the lived experiences of individuals with oromandibular dystonia. 
 
PRINCIPAL INVESTIGATOR 
Allyson Dykstra, Ph.D. 
Assistant Professor 
School of Communication Sciences and Disorders, Western University 
 
CO-INVESTIGATOR 
Dr. Mandar Jog, MD, FRCPC, Professor 
Director, Movement Disorders Program 
London Health Sciences Centre, University Campus and Western University 
 
INTRODUCTION 
This letter of information describes a research study and what you may expect if you decide to participate. 
You should read the letter carefully and ask the person discussing this with you any questions that you 
may have before making a decision whether or not to participate. This form contains important 
information and telephone numbers, so you should keep this copy for future reference. If you decide not 
to participate in this study, the decision will not be held against you and will not affect your treatment in 
any way.  
You are being asked to participate in this research study because you are an individual with 
oromandibular dystonia (OMD). The purpose of this study is to investigate the effects of oromandibular 
dystonia on your speech intelligibility (how understandable your speech is), your level of speech usage, your 
level of apprehension or concern when you are communicating orally, your self-perceived communicative 
competence, your effectiveness as a communicator in different social settings and your quality of life as it 
relates to communication. An additional purpose of this study is to compare how the Botox© injections you 
are receiving to manage your dystonia affects your speech intelligibility, your communicative apprehension, 
communication effectiveness and communication-related quality of life. We are also interested in learning 
about your experience of having oromandibular dystonia. 
 
This study will involve 30 participants with OMD. Information about participants will be collected from 
patient charts and person-to-person interviews by the principal experimenter or another designated 
member of the research team. This will include information about the participant’s date of birth, general 
medical history, neurological history, and speech and hearing history. 
  
This study will be conducted over two sessions, separated by approximately one month and lasting 
approximately 40 minutes for the first visit and approximately 2 hours for the second visit.  Both visits 
will involve speech recordings of your voice. During this 10 minute recording period you will be asked to 
read aloud a series of 57 single words and 11 sentences while being recorded with a microphone. Both 
visits will also involve completing a series of six questionnaires that will look at how you use your speech 
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on a daily basis, your level of concern or apprehension when you are communicating orally, your self-
perceived competence when communicating, your effectiveness as a communicator in different social 
situations and your quality of life as it relates to your communication. It is anticipated that completion of 
the questionnaires will take approximately 30 minutes.  The second visit will involve an additional 60-90 
minute one-time in-person interview with the researchers into order to learn more about your experiences 
of living with oromandibular dystonia. During this interview we will ask you to share stories and 
information about strategies you have used to help you participate in life activities due to having dystonia. 
We want to hear about strategies that worked well and those that did not work well. In particular, we want 
to hear about things that make you more or less confident about your participation in activities. We want 
to hear your recommendations that you would give to other people in similar circumstances. You do not 
need to answer any questions you do not want to answer. The interview will be audio-recorded. Only the 
researchers will have access to the recording of the interview. The audio file would be stored on a secure 
server at Western University. 
 
The first visit will be completed during your scheduled clinic visit at the Movement Disorders Clinic. The 
second visit will be scheduled approximately one month later to ensure that your Botox© treatment is 
working optimally.  
 
 If you agree to participate you will be able to complete the first visit of the study directly following your 
scheduled appointment time at the Movement Disorders Clinic in a separate testing room located within 
University Hospital. For the second visit of the study you will be asked to come to the Principal 
Investigator’s Lab in Elborn College (Room 2592) at the University of Western Ontario for repeat 
administration of questionnaires, speech recordings and the in-person interview. While at Elborn College, 
you will be provided with free parking.   
 
The experimental procedures will require very little physical effort, and there is no known discomfort or risk 
involved in performing them.  You will be seated in a comfortable chair throughout the procedures and 
during the interview and you will be given rest breaks approximately every five minutes or more frequently if 
required. 
 
The procedures that will be used during this study are experimental in nature and will not provide any direct 
benefit to the participant’s medical condition, however, it is anticipated that results from this study may 
provide important information about the effect of oromandibular dystonia on speech intelligibility, one’s 
perception of their apprehension when communicating orally, their level of speech usage, their perception 
of how effective they are as communicators, and their quality of life as it relates to communication. It may 
also provide important information about the effect of Botox© on speech intelligibility, communication 
apprehension, communicative effectiveness and communication-related quality of life. Financial 
compensation will not be provided upon completion of this study. Parking costs over and above your 
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regular clinic visit at the Movement Disorders Clinic will not be reimbursed. While at Elborn College, 
you will be provided with free parking. 
 
Participation in this study is voluntary. You may refuse to participate, refuse to answer any questions, or 
withdraw from the study at any time with no effect on your future care. 
  
All of the information obtained in this study will be held in strict confidence. Your name and any identifying 
information will be removed from the data. If the results of the study are published, your name will not be 
used and no information that discloses your identity will be released or published. Representatives of 
Western University’s Health Sciences Research Ethics Board may contact you or require access to your 
study-related records to monitor the conduct of the research. You do not waive any legal rights by signing 
the consent form.   
 
Throughout the study, all confidential information and data will be preserved in a locked filing cabinet in 
the Principal Investigator’s laboratory at Elborn College, Western University. All study materials will be 
destroyed after 25 years. 
 
If requested, you will be provided with a copy of any publication related to the results of this study when 
it becomes available. 
 
If you have any questions or would like additional information about this study, please contact Professor 
Allyson Dykstra at the School of Communication Sciences and Disorders, Elborn College, Western 
University, London, Ontario, N6G 1H1 (Phone: (519) 661-2111 x 88940). If you have any questions about 
the conduct of this study or your rights as a research subject you may contact Dr. David Hill, Scientific 
Director, Lawson Health Research Institute at (519) 667-6649. 
 
If you agree to participate in this study, please sign the consent form on the next page. 
 
 
Sincerely, 
Allyson Dykstra, PhD  
Assistant Professor 
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APPENDIX B 
Consent Form 
 
 
STUDY TITLE 
The effects botulinum toxin A on speech intelligibility, levels of speech usage, communication 
apprehension, self-perceived communication competence, communicative effectiveness, communication-
related quality of life and the lived experiences of individuals with oromandibular dystonia. 
 
PRINCIPAL INVESTIGATOR 
Allyson Dykstra, Ph.D. 
Assistant Professor 
School of Communication Sciences and Disorders, Western University 
 
 
CO-INVESTIGATOR 
Dr. Mandar Jog, MD, FRCPC, Professor 
Director, Movement Disorders Program 
London Health Sciences Centre, University Campus and Western University 
 
 
 
I have read the Letter of Information, have had the nature of the study explained to me and I agree to 
participate. All questions have been answered to my satisfaction. 
 
 
 
________________________  ________________________ ________________ 
Signature of Research Subject       Printed Name     Date 
 
 
 
 
_______________________________    ________________________ _________________ 
Signature of Person Obtaining Consent Printed Name     Date 
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APPENDIX C 
Ethics Approval Notice
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APPENDIX D 
Phoneme Intelligibility Test (PIT) – Single words 
 
Sample word list from the Phoneme Intelligibility Test – Single words 
 
 1.  herd 30.  that 
 2.  taught 31.  towed 
 3.  made 32.  chat 
 4.  Jan 33.  man 
 5.  made 34.  mate 
 6.  load 35.  lug 
 7.  bat 36.  can 
 8.  mule 37.  shine 
 9.  Jane 38.  meal 
10.  foil 39.  seat 
11.  mod 40.  lodge 
12.  loin 41.  lush 
13.  loaf 42.  maim 
14.  ham 43.  fall 
15.  boy 44.  bee 
16.  caught 45.  time 
17.  male 46.  sat 
18.  thine 47.  tame 
19.  Tim 48.  she'd 
20.  mood 49.  file 
21.  lobe 50.  mop 
22.  men 51.  peat 
23.  man 52.  main 
24.  Pam 53.  ice 
25.  lung 54.  bin 
26.  mod 55.  rug 
27.  men 56.  shine 
28.  Dan 57.  towed 
29.  dam  
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APPENDIX E 
 
Sentence Intelligibility Test (SIT) 
 
Sample sentences from the short version of the Sentence Intelligibility Test  
 
 
5A. Do you like doing math? 
 
 
6A. Their house is grey and white. 
 
 
7A. It was very popular with our fans. 
 
 
8A. This is a period of transition for me. 
 
 
9A. You can rent a mower from many garden stores. 
 
 
10A. The patient managed to fall and break his ankle again. 
 
 
11A. We saw a mother bear leading her cubs up the hill. 
 
 
12A. There are no judges to intimidate you, or lawyers making obscure points. 
 
 
13A. After you've finished answering all the questions, please mail the card to us. 
 
 
14A. The sun never reaches the ground through the overhead canopy of trees and vines. 
 
 
15A. It was the exact same feeling you get when your knee gives out on you. 
  
89 
 
 
 
APPENDIX F 
 VAS Samples 
Single-word Intelligibility: VAS 
Instructions for listeners: 
You will be listening to a series of single words.  Following each series of words, you will be 
required to rate the intelligibility or understandablility of the series. Samples will only be 
presented once. 
 
Single word series 1: 
 
Intelligibility Rating 
Please rate your perception of how intelligible/understandable the series of single words were. 
|_________________________________________________| 
                       0%                                                                                         100% 
 
Sentence Intelligibility: VAS 
 
Instructions for listeners: 
You will be listening to a series of sentences.  Following each series of sentences, you will be 
required to rate the intelligibility or understandablility of the series. Samples will only be 
presented once. 
 
Sentence series 1: 
 
Intelligibility Rating 
Please rate your perception of how intelligible/understandable the series of sentences were. 
|_________________________________________________| 
                       0%                                                                                         100% 
 
Conversational Intelligibility: VAS  
 
 
Instructions for listeners: 
You will be listening to 20 conversational excerpts ranging in length from 30 to 45 seconds each.  
Following each conversational excerpt, you will be required to rate the intelligibility or 
understandablility of each. Samples will only be presented once. 
 
Conversational Excerpt 1: 
 
Intelligibility Rating 
Please rate your perception of how intelligible/understandable the phrases in the conversation 
were. 
 
|_________________________________________________| 
                       0%                                                                                         100% 
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APPENDIX G 
 Inter-rater Reliability 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.973 .976 5 
 
Intraclass Correlation Coefficient 
 Intraclass 
Correlationb 
95% Confidence Interval F Test with True Value 0 
Lower Bound Upper Bound Value df1 df2 
Single Measures .846a .687 .943 37.704 12 48 
Average Measures .965c .916 .988 37.704 12 48 
 
Intraclass Correlation Coefficient 
 F Test with True Value 0b 
Sig 
Single Measures .000a 
Average Measures .000c 
 
Two-way mixed effects model where people effects are random and measures effects are fixed. 
a. The estimator is the same, whether the interaction effect is present or not. 
b. Type A intraclass correlation coefficients using an absolute agreement definition. 
c. This estimate is computed assuming the interaction effect is absent, because it is not estimable otherwise. 
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APPENDIX H  
Intra-rater Reliability  
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based on 
Standardized 
Items 
N of Items 
.987 .987 2 
 
Intraclass Correlation Coefficient 
 Intraclass 
Correlationb 
95% Confidence Interval F Test with True Value 0 
Lower Bound Upper Bound Value df1 df2 
Single Measures .973a .956 .984 76.567 64 64 
Average Measures .987c .978 .992 76.567 64 64 
 
Intraclass Correlation Coefficient 
 F Test with True Value 0b 
Sig 
Single Measures .000a 
Average Measures .000c 
 
Two-way mixed effects model where people effects are random and measures effects are fixed. 
a. The estimator is the same, whether the interaction effect is present or not. 
b. Type A intraclass correlation coefficients using an absolute agreement definition. 
c. This estimate is computed assuming the interaction effect is absent, because it is not estimable otherwise. 
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APPENDIX I 
Repeated Measures MANOVA: Time (Orthographic Transcription)  
 
Descriptive Statistics 
 Mean Std. Deviation N 
SITpre_tot_ave 
90.9090909090
91120 
10.39707524036
0687 
10 
SITpost_tot_ave 
89.6545454545
45570 
12.98623980382
4155 
10 
PITpre_tot_ave 
76.6502463054
18800 
10.83618505465
6324 
10 
PITpost_tot_ave 
76.1979802955
66610 
14.61830449249
7483 
10 
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Multivariate Testsa 
Effect Value F Hypothesis df Error df 
Between Subjects Intercept 
Pillai's Trace .986 273.228b 2.000 8.000 
Wilks' Lambda .014 273.228b 2.000 8.000 
Hotelling's Trace 68.307 273.228b 2.000 8.000 
Roy's Largest Root 68.307 273.228b 2.000 8.000 
Within Subjects time 
Pillai's Trace .087 .381b 2.000 8.000 
Wilks' Lambda .913 .381b 2.000 8.000 
Hotelling's Trace .095 .381b 2.000 8.000 
Roy's Largest Root .095 .381b 2.000 8.000 
 
 
Multivariate Testsa 
Effect Sig. Partial Eta Squared 
Between Subjects Intercept 
Pillai's Trace .000 .986b 
Wilks' Lambda .000 .986b 
Hotelling's Trace .000 .986b 
Roy's Largest Root .000 .986b 
Within Subjects time 
Pillai's Trace .695 .087b 
Wilks' Lambda .695 .087b 
Hotelling's Trace .695 .087b 
Roy's Largest Root .695 .087b 
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Tests of Within-Subjects Effects 
 
Multivariatea,b 
Within Subjects Effect Value F Hypothesis df Error df Sig. 
time 
Pillai's Trace .087 .381c 2.000 8.000 .695 
Wilks' Lambda .913 .381c 2.000 8.000 .695 
Hotelling's Trace .095 .381c 2.000 8.000 .695 
Roy's Largest Root .095 .381c 2.000 8.000 .695 
 
Multivariatea,b 
Within Subjects Effect Partial Eta Squared 
time 
Pillai's Trace .087 
Wilks' Lambda .087 
Hotelling's Trace .087 
Roy's Largest Root .087 
 
a. Design: Intercept  
 Within Subjects Design: time 
b. Tests are based on averaged variables. 
c. Exact statistic 
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Univariate Tests 
Source Measure Type III Sum of 
Squares 
df Mean Square F 
time 
SIT_OT_ave 
Sphericity Assumed 7.869 1 7.869 .725 
Greenhouse-Geisser 7.869 1.000 7.869 .725 
Huynh-Feldt 7.869 1.000 7.869 .725 
Lower-bound 7.869 1.000 7.869 .725 
PIT_OT_ave 
Sphericity Assumed 1.023 1 1.023 .022 
Greenhouse-Geisser 1.023 1.000 1.023 .022 
Huynh-Feldt 1.023 1.000 1.023 .022 
Lower-bound 1.023 1.000 1.023 .022 
Error(time) 
SIT_OT_ave 
Sphericity Assumed 97.734 9 10.859  
Greenhouse-Geisser 97.734 9.000 10.859  
Huynh-Feldt 97.734 9.000 10.859  
Lower-bound 97.734 9.000 10.859  
PIT_OT_ave 
Sphericity Assumed 428.036 9 47.560  
Greenhouse-Geisser 428.036 9.000 47.560  
Huynh-Feldt 428.036 9.000 47.560  
Lower-bound 428.036 9.000 47.560  
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Univariate Tests 
Source Measure Sig. Partial Eta Squared 
time 
SIT_OT_ave 
Sphericity Assumed .417 .075 
Greenhouse-Geisser .417 .075 
Huynh-Feldt .417 .075 
Lower-bound .417 .075 
PIT_OT_ave 
Sphericity Assumed .887 .002 
Greenhouse-Geisser .887 .002 
Huynh-Feldt .887 .002 
Lower-bound .887 .002 
Error(time) 
SIT_OT_ave 
Sphericity Assumed   
Greenhouse-Geisser   
Huynh-Feldt   
Lower-bound   
PIT_OT_ave 
Sphericity Assumed   
Greenhouse-Geisser   
Huynh-Feldt   
Lower-bound   
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APPENDIX J  
Repeated Measures MANOVA: Time (VAS) 
Descriptive Statistics 
 Mean Std. Deviation N 
VASpre_tot_ave 81.1850 14.93213 10 
VASpost_tot_ave 80.9300 15.65324 10 
PITVASpre_tot_ave 
75.5000000000
00100 
12.2484466135
28053 
10 
PITVASpost_tot_ave 
78.0750000000
00100 
13.5945097169
57324 
10 
Conv_pre_total_ave 74.870 21.2295 10 
Conv_post_total_ave 73.690 19.0867 10 
 
Multivariate Testsa 
Effect Value F Hypothesis df Error df 
Between Subjects Intercept 
Pillai's Trace .979 110.527b 3.000 7.000 
Wilks' Lambda .021 110.527b 3.000 7.000 
Hotelling's Trace 47.369 110.527b 3.000 7.000 
Roy's Largest Root 47.369 110.527b 3.000 7.000 
Within Subjects time 
Pillai's Trace .272 .873b 3.000 7.000 
Wilks' Lambda .728 .873b 3.000 7.000 
Hotelling's Trace .374 .873b 3.000 7.000 
Roy's Largest Root .374 .873b 3.000 7.000 
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Multivariate Testsa 
Effect Sig. Partial Eta Squared 
Between Subjects Intercept 
Pillai's Trace .000 .979b 
Wilks' Lambda .000 .979b 
Hotelling's Trace .000 .979b 
Roy's Largest Root .000 .979b 
Within Subjects time 
Pillai's Trace .499 .272b 
Wilks' Lambda .499 .272b 
Hotelling's Trace .499 .272b 
Roy's Largest Root .499 .272b 
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APPENDIX K 
 
Two Factor Repeated Measures MANOVA: Time and Order 
 
 
Multivariate Testsa 
Effect Value F Hypothesis df 
Between Subjects Intercept 
Pillai's Trace .990 142.082b 4.000 
Wilks' Lambda .010 142.082b 4.000 
Hotelling's Trace 94.722 142.082b 4.000 
Roy's Largest Root 94.722 142.082b 4.000 
Within Subjects 
time 
Pillai's Trace .471 1.333b 4.000 
Wilks' Lambda .529 1.333b 4.000 
Hotelling's Trace .889 1.333b 4.000 
Roy's Largest Root .889 1.333b 4.000 
a_vs_b 
Pillai's Trace .690 3.342b 4.000 
Wilks' Lambda .310 3.342b 4.000 
Hotelling's Trace 2.228 3.342b 4.000 
Roy's Largest Root 2.228 3.342b 4.000 
time * a_vs_b 
Pillai's Trace .413 1.056b 4.000 
Wilks' Lambda .587 1.056b 4.000 
Hotelling's Trace .704 1.056b 4.000 
Roy's Largest Root .704 1.056b 4.000 
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Multivariate Testsa 
Effect Error df Sig. Partial Eta 
Squared 
Between Subjects Intercept 
Pillai's Trace 6.000 .000b .990 
Wilks' Lambda 6.000 .000b .990 
Hotelling's Trace 6.000 .000b .990 
Roy's Largest Root 6.000 .000b .990 
Within Subjects 
time 
Pillai's Trace 6.000 .358b .471 
Wilks' Lambda 6.000 .358b .471 
Hotelling's Trace 6.000 .358b .471 
Roy's Largest Root 6.000 .358b .471 
a_vs_b 
Pillai's Trace 6.000 .091b .690 
Wilks' Lambda 6.000 .091b .690 
Hotelling's Trace 6.000 .091b .690 
Roy's Largest Root 6.000 .091b .690 
time * a_vs_b 
Pillai's Trace 6.000 .453b .413 
Wilks' Lambda 6.000 .453b .413 
Hotelling's Trace 6.000 .453b .413 
Roy's Largest Root 6.000 .453b .413 
 
a. Design: Intercept  
 Within Subjects Design: time + a_vs_b + time * a_vs_b 
b. Exact statistic 
  
101 
 
 
 
Univariate Tests 
Source Measure Type III 
Sum of 
Squares 
df Mean 
Square 
F Sig. Partial Eta 
Squared 
time 
SIT_OT 
Sphericity 
Assumed 
15.735 1 15.735 .717 .419 .074 
Greenhouse-
Geisser 
15.735 1.000 15.735 .717 .419 .074 
Huynh-Feldt 15.735 1.000 15.735 .717 .419 .074 
Lower-bound 15.735 1.000 15.735 .717 .419 .074 
SIT_VA
S 
Sphericity 
Assumed 
30.800 1 30.800 1.623 .235 .153 
Greenhouse-
Geisser 
30.800 1.000 30.800 1.623 .235 .153 
Huynh-Feldt 30.800 1.000 30.800 1.623 .235 .153 
Lower-bound 30.800 1.000 30.800 1.623 .235 .153 
PIT_OT 
Sphericity 
Assumed 
2.045 1 2.045 .022 .887 .002 
Greenhouse-
Geisser 
2.045 1.000 2.045 .022 .887 .002 
Huynh-Feldt 2.045 1.000 2.045 .022 .887 .002 
Lower-bound 2.045 1.000 2.045 .022 .887 .002 
PIT_VA
S 
Sphericity 
Assumed 
66.306 1 66.306 .693 .427 .072 
Greenhouse-
Geisser 
66.306 1.000 66.306 .693 .427 .072 
Huynh-Feldt 66.306 1.000 66.306 .693 .427 .072 
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Lower-bound 66.306 1.000 66.306 .693 .427 .072 
Error(time) 
SIT_OT 
Sphericity 
Assumed 
197.544 9 21.949    
Greenhouse-
Geisser 
197.544 9.000 21.949    
Huynh-Feldt 197.544 9.000 21.949    
Lower-bound 197.544 9.000 21.949    
SIT_VA
S 
Sphericity 
Assumed 
170.782 9 18.976    
Greenhouse-
Geisser 
170.782 9.000 18.976    
Huynh-Feldt 170.782 9.000 18.976    
Lower-bound 170.782 9.000 18.976    
PIT_OT 
Sphericity 
Assumed 
856.072 9 95.119    
Greenhouse-
Geisser 
856.072 9.000 95.119    
Huynh-Feldt 856.072 9.000 95.119    
Lower-bound 856.072 9.000 95.119    
PIT_VA
S 
Sphericity 
Assumed 
860.511 9 95.612    
Greenhouse-
Geisser 
860.511 9.000 95.612    
Huynh-Feldt 860.511 9.000 95.612    
Lower-bound 860.511 9.000 95.612    
a_vs_b SIT_OT 
Sphericity 
Assumed 
275.252 1 275.252 11.720 .008 .566 
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Greenhouse-
Geisser 
275.252 1.000 275.252 11.720 .008 .566 
Huynh-Feldt 275.252 1.000 275.252 11.720 .008 .566 
Lower-bound 275.252 1.000 275.252 11.720 .008 .566 
SIT_VA
S 
Sphericity 
Assumed 
156.420 1 156.420 7.499 .023 .455 
Greenhouse-
Geisser 
156.420 1.000 156.420 7.499 .023 .455 
Huynh-Feldt 156.420 1.000 156.420 7.499 .023 .455 
Lower-bound 156.420 1.000 156.420 7.499 .023 .455 
PIT_OT 
Sphericity 
Assumed 
16.507 1 16.507 .511 .493 .054 
Greenhouse-
Geisser 
16.507 1.000 16.507 .511 .493 .054 
Huynh-Feldt 16.507 1.000 16.507 .511 .493 .054 
Lower-bound 16.507 1.000 16.507 .511 .493 .054 
PIT_VA
S 
Sphericity 
Assumed 
165.242 1 165.242 11.078 .009 .552 
Greenhouse-
Geisser 
165.242 1.000 165.242 11.078 .009 .552 
Huynh-Feldt 165.242 1.000 165.242 11.078 .009 .552 
Lower-bound 165.242 1.000 165.242 11.078 .009 .552 
Error(a_vs_b) SIT_OT 
Sphericity 
Assumed 
211.363 9 23.485    
Greenhouse-
Geisser 
211.363 9.000 23.485    
Huynh-Feldt 211.363 9.000 23.485    
Lower-bound 211.363 9.000 23.485    
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SIT_VA
S 
Sphericity 
Assumed 
187.732 9 20.859    
Greenhouse-
Geisser 
187.732 9.000 20.859    
Huynh-Feldt 187.732 9.000 20.859    
Lower-bound 187.732 9.000 20.859    
PIT_OT 
Sphericity 
Assumed 
290.653 9 32.295    
Greenhouse-
Geisser 
290.653 9.000 32.295    
Huynh-Feldt 290.653 9.000 32.295    
Lower-bound 290.653 9.000 32.295    
PIT_VA
S 
Sphericity 
Assumed 
134.245 9 14.916    
Greenhouse-
Geisser 
134.245 9.000 14.916    
Huynh-Feldt 134.245 9.000 14.916    
Lower-bound 134.245 9.000 14.916    
time * a_vs_b 
SIT_OT 
Sphericity 
Assumed 
.010 1 .010 .001 .974 .000 
Greenhouse-
Geisser 
.010 1.000 .010 .001 .974 .000 
Huynh-Feldt .010 1.000 .010 .001 .974 .000 
Lower-bound .010 1.000 .010 .001 .974 .000 
SIT_VA
S 
Sphericity 
Assumed 
2.352 1 2.352 .691 .427 .071 
Greenhouse-
Geisser 
2.352 1.000 2.352 .691 .427 .071 
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Huynh-Feldt 2.352 1.000 2.352 .691 .427 .071 
Lower-bound 2.352 1.000 2.352 .691 .427 .071 
PIT_OT 
Sphericity 
Assumed 
19.461 1 19.461 2.796 .129 .237 
Greenhouse-
Geisser 
19.461 1.000 19.461 2.796 .129 .237 
Huynh-Feldt 19.461 1.000 19.461 2.796 .129 .237 
Lower-bound 19.461 1.000 19.461 2.796 .129 .237 
PIT_VA
S 
Sphericity 
Assumed 
25.440 1 25.440 4.993 .052 .357 
Greenhouse-
Geisser 
25.440 1.000 25.440 4.993 .052 .357 
Huynh-Feldt 25.440 1.000 25.440 4.993 .052 .357 
Lower-bound 25.440 1.000 25.440 4.993 .052 .357 
Error(time*a_vs
_b) 
SIT_OT 
Sphericity 
Assumed 
82.823 9 9.203    
Greenhouse-
Geisser 
82.823 9.000 9.203    
Huynh-Feldt 82.823 9.000 9.203    
Lower-bound 82.823 9.000 9.203    
SIT_VA
S 
Sphericity 
Assumed 
30.640 9 3.404    
Greenhouse-
Geisser 
30.640 9.000 3.404    
Huynh-Feldt 30.640 9.000 3.404    
Lower-bound 30.640 9.000 3.404    
106 
 
 
 
PIT_OT 
Sphericity 
Assumed 
62.645 9 6.961    
Greenhouse-
Geisser 
62.645 9.000 6.961    
Huynh-Feldt 62.645 9.000 6.961    
Lower-bound 62.645 9.000 6.961    
PIT_VA
S 
Sphericity 
Assumed 
45.857 9 5.095    
Greenhouse-
Geisser 
45.857 9.000 5.095    
Huynh-Feldt 45.857 9.000 5.095    
Lower-bound 45.857 9.000 5.095    
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Appendix L 
Pearson Correlation: Pre-BoNT-A 
 
Correlations 
 SITpre_tot_ave VASpre_tot_ave PITpre_tot_ave 
SITpre_tot_ave 
Pearson Correlation 1 .901** .753* 
Sig. (2-tailed)  .000 .012 
N 10 10 10 
VASpre_tot_ave 
Pearson Correlation .901** 1 .728* 
Sig. (2-tailed) .000  .017 
N 10 10 10 
PITpre_tot_ave 
Pearson Correlation .753* .728* 1 
Sig. (2-tailed) .012 .017  
N 10 10 10 
PITVASpre_tot_ave 
Pearson Correlation .808** .856** .760* 
Sig. (2-tailed) .005 .002 .011 
N 10 10 10 
Conv_pre_total_ave 
Pearson Correlation .389 .639* .444 
Sig. (2-tailed) .267 .047 .198 
N 10 10 10 
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Correlations 
 PITVASpre_tot_ave Conv_pre_total_ave 
SITpre_tot_ave 
Pearson Correlation .808 .389** 
Sig. (2-tailed) .005 .267 
N 10 10 
VASpre_tot_ave 
Pearson Correlation .856** .639 
Sig. (2-tailed) .002 .047 
N 10 10 
PITpre_tot_ave 
Pearson Correlation .760* .444* 
Sig. (2-tailed) .011 .198 
N 10 10 
PITVASpre_tot_ave 
Pearson Correlation 1** .382** 
Sig. (2-tailed)  .275 
N 10 10 
Conv_pre_total_ave 
Pearson Correlation .382 1* 
Sig. (2-tailed) .275  
N 10 10 
 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Appendix M  
Pearson Correlation: Post-BoNT-A 
Correlations 
 SITpost_tot_ave VASpost_tot_av
e 
PITpost_tot_ave 
SITpost_tot_ave 
Pearson Correlation 1 .907** .756* 
Sig. (2-tailed)  .000 .011 
N 10 10 10 
VASpost_tot_ave 
Pearson Correlation .907** 1 .786** 
Sig. (2-tailed) .000  .007 
N 10 10 10 
PITpost_tot_ave 
Pearson Correlation .756* .786** 1 
Sig. (2-tailed) .011 .007  
N 10 10 10 
PITVASpost_tot_ave 
Pearson Correlation .847** .899** .906** 
Sig. (2-tailed) .002 .000 .000 
N 10 10 10 
Conv_post_total_ave 
Pearson Correlation .578 .815** .535 
Sig. (2-tailed) .080 .004 .111 
N 10 10 10 
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Correlations 
 PITVASpost_tot_ave Conv_post_total_ave 
SITpost_tot_ave 
Pearson Correlation .847 .578** 
Sig. (2-tailed) .002 .080 
N 10 10 
VASpost_tot_ave 
Pearson Correlation .899** .815 
Sig. (2-tailed) .000 .004 
N 10 10 
PITpost_tot_ave 
Pearson Correlation .906* .535** 
Sig. (2-tailed) .000 .111 
N 10 10 
PITVASpost_tot_ave 
Pearson Correlation 1** .687** 
Sig. (2-tailed)  .028 
N 10 10 
Conv_post_total_ave 
Pearson Correlation .687 1** 
Sig. (2-tailed) .028  
N 10 10 
 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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